EurekaMag PDF full texts Chapter 8,088

Tsai, S.-Chen; Adamik, R.; Moss, J.; Vaughan, M. 1995: ADP-ribosylation Factors: ARF Structure and Function. Zoological Studies 34(1): 1-9

Zahradka, P.; Yau, L. 1994: ADP-ribosylation and gene expression. Molecular and Cellular Biochemistry 138(1-2): 91-98

Hildebrandt, K.; Eastman, D.; Dworkin, M. 1997: ADP-ribosylation by the extracellular fibrils of Myxococcus xanthus. Molecular Microbiology 23(2): 231-235

Ooi, C.E.; Dell'Angelica, E.C.; Bonifacino, J.S. 1998: ADP-ribosylation factor 1 (ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. Journal of Cell Biology 142(2): 391-402

Zhu, Y.; Traub, L.M.; Kornfeld, S. 1998: ADP-ribosylation factor 1 transiently activates high-affinity adaptor protein complex AP-1 binding sites on Golgi membranes. Molecular Biology of the Cell 9(6): 1323-1337

Whatmore, J.; Morgan, C.P.; Cunningham, E.; Collison, K.S.; Willison, K.R.; Cockcroft, S. 1996: ADP-ribosylation factor 1-regulated phospholipase D activity is localized at the plasma membrane and intracellular organelles in HL60 cells. Biochemical Journal 320: 785-794

Radhakrishna, H.; Donaldson, J.G. 1997: ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. Journal of Cell Biology 139(1): 49-61

Fensome, A.; Whatmore, J.; Morgan, C.; Jones, D.; Cockcroft, S. 1998: ADP-ribosylation factor and Rho proteins mediate fMLP-dependent activation of phospholipase D in human neutrophils. Journal of Biological Chemistry 273(21): 13157-13164

Elazar, Z.; Orci, L.; Ostermann, J.; Amherdt, M.; Tanigawa, G.; Rothman, J.E. 1994: ADP-ribosylation factor and coatomer couple fusion to vesicle budding. Journal of Cell Biology 124(4): 415-424

Lambeth, J.D.; Kwak, J.Y.; Bowman, E.P.; Perry, D.; Uhlinger, D.J.; Lopez, I. 1995: ADP-ribosylation factor functions synergistically with a 50-kDa cytosolic factor in cell-free activation of human neutrophil phospholipase D. Journal of Biological Chemistry 270(6): 2431-2434

Brown, H.A.; Gutowski, S.; Moomaw, C.R.; Slaughter, C.; Sternweis, P.C. 1993: ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell 75(6): 1137-1144

Chen, Y.G.; Shields, D. 1996: ADP-ribosylation factor-1 stimulates formation of nascent secretory vesicles from the trans-Golgi network of endocrine cells. Journal of Biological Chemistry 271(10): 5297-5300

Makler, V.; Cukierman, E.; Rotman, M.; Admon, A.; Cassel, D. 1995: ADP-ribosylation factor-directed GTPase-activating protein. Purification and partial characterization. Journal of Biological Chemistry 270(10): 5232-5237

Rudge, S.A.; Cavenagh, M.M.; Kamath, R.; Sciorra, V.A.; Morris, A.J.; Kahn, R.A.; Engebrecht, J. 1998: ADP-Ribosylation factors do not activate yeast phospholipase Ds but are required for sporulation. Molecular Biology of the Cell 9(8): 2025-2036

Welsh, C., F.; Moss, J.; Vaughan, M. 1994: ADP-ribosylation factors: A family of apprx 20-kDa guanine nucleotide-binding proteins that activate cholera toxin. Molecular and Cellular Biochemistry 138: 157-166

Fujita, H.; Okamoto, H.; Tsuyama, S. 1995: ADP-ribosylation in adrenal glands: Purification and characterization of mono-ADP-ribosyltransferases and ADP-ribosylhydrolase affecting cytoskeletal actin. International Journal of Biochemistry and Cell Biology 27(10): 1065-1078

Terashima, M.; Shimoyama, M. 1993: ADP-ribosylation of A-1 peptide of cholera toxin by chicken arginine-specific ADP-ribosyltransferase with a concomitant increase in ADP-ribosyltransferase activity of the peptide. Biomedical Research 14(5): 329-335

Terashima, M.; Yamamori, C.; Shimoyama, M. 1995: ADP-ribosylation of Arg28 and Arg206 on the actin molecule by chicken arginine-specific ADP-ribosyltransferase. European Journal of Biochemistry 231(1): 242-249

Just, I.; Hennessey, E.S.; Drummond, D.R.; Aktories, K.; Sparrow, J.C. 1993: ADP-ribosylation of Drosophila indirect-flight-muscle actin and arthrin by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin. Biochemical Journal 291: 409-412

Bornancin, F.; Audigier, Y.; Chabre, M. 1993: ADP-ribosylation of Gs by cholera toxin is potentiated by agonist activation of beta-adrenergic receptors in the absence of GTP. Journal of Biological Chemistry 268(23): 17026-17029

Ehrengruber, M.U.; Boquet, P.; Coates, T.D.; Deranleau, D.A. 1995: ADP-ribosylation of Rho enhances actin polymerization-coupled shape oscillations in human neutrophils. Febs Letters 372(2-3): 161-164

Fritz, G.; Aktories, K. 1994: ADP-ribosylation of Rho proteins by Clostridium botulinum exoenzyme C3 is influenced by phosphorylation of Rho-associated factors. Biochemical Journal 300: 133-139

Verschueren, H.; De Baetselier, P.; De Braekeleer, J.; Dewit, J.; Aktories, K.; Just, I. 1997: ADP-ribosylation of Rho-proteins with botulinum C3 exoenzyme inhibits invasion and shape changes of T-lymphoma cells. European Journal of Cell Biology 73(2): 182-187

Sehr, P.; Just, I.; Aktories, K. 1996: ADP-ribosylation of actin by Clostridium perfringens iota toxin and turkey erythrocyte ADP-ribosyltransferase A: Effects on profilin-regulated nucleotide exchange and ATPase activity. Naunyn-Schmiedeberg's Archives of Pharmacology 354(6): 693-697

Grolig, F.; Just, I.; Aktories, K. 1996: ADP-ribosylation of actin from the green alga Chara corallina by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin. Protoplasma 193(1-4): 77-81

Rønnov-Jessen, L.; Petersen, O.W. 1996: ADP-ribosylation of actins in fibroblasts and myofibroblasts by botulinum C2 toxin: influence on microfilament morphology and migratory behavior. Electrophoresis 17(11): 1776-1780

Palkiewicz, P.; Zwiers, H.; Lorscheider, F.L. 1994: ADP-ribosylation of brain neuronal proteins is altered by in vitro and in vivo exposure to inorganic mercury. Journal of Neurochemistry 62(5): 2049-2052

Prasad, S.; Walent, J.; Dritschilo, A. 1994: ADP-ribosylation of heterogeneous ribonucleoproteins in Hela cells. Biochemical and Biophysical Research Communications 204(2): 772-779

Nurten, R.; Ustündağ, I.; Sayhan, N.; Bermek, E. 1994: ADP-ribosylation of human serum proteins promoted by endogenous NAD glycohydrolase activity. Biochemical and Biophysical Research Communications 200(1): 450-458

Jesser, M.; Hog, F.; Chypre, C.; Leterrier, J.F.; Mandel, P. 1993: ADP-ribosylation of neurofilaments by a cytoplasmic ADP-ribose transferase associated with free mRNP. Biochemical and Biophysical Research Communications 194(2): 916-922

Scovassi, A.I.; Mariani, C.; Negroni, M.; Negri, C.; Bertazzoni, U. 1993: ADP-ribosylation of nonhistone proteins in HeLa cells: Modification of DNA topoisomerase II. Experimental Cell Research 206(1): 177-181

Leitinger, N.; Wesierska-Gadek, J. 1993: ADP-ribosylation of nucleolar proteins in Hela tumor cells. Journal of Cellular Biochemistry 52(2): 153-158

Wesierska-Gadek, J.; Bugajska-Schretter, A.; Cerni, C. 1996: ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified. Journal of Cellular Biochemistry 62(1): 90-101

Huh, J.W.; Shima, J.; Ochi, K. 1996: ADP-ribosylation of proteins in Bacillus subtilis and its possible importance in sporulation. Journal of Bacteriology 178(16): 4935-4941

Kodama, H.; Ohishi, I. 1993: ADP-ribosylation of rainbow trout (Oncorhynchus mykiss) actin by botulinum C2 toxin. Infection and Immunity 61(12): 5392-5393

Kumagai, N.; Morii, N.; Fujisawa, K.; Nemoto, Y.; Narumiya, S. 1993: ADP-ribosylation of rho p21 inhibits lysophosphatidic acid-induced protein tyrosine phosphorylation and phosphatidylinositol 3-kinase activated in cultured Swiss 3T3 cells. Journal of Biological Chemistry 268(33): 24535-24538

Albeniz, I.U.; Nurten, R.; Bermek, E. 1997: ADP-ribosylation of serum proteins: elevated levels in neoplastic cases due to altered NAD/ADP-ribose metabolism. Cancer Investigation 15(3): 217-223

Albeniz, I.U.; Nurten, R.; Bermek, E. 1996: ADP-ribosylation of serum proteins: Evaluation as a potential tumor marker. Cancer Letters 108(2): 239-245

Udagawa, T.; McIntyre, B.W. 1996: ADP-ribosylation of the G protein Rho inhibits integrin regulation of tumor cell growth. Journal of Biological Chemistry 271(21): 12542-12548

Koch, G.; Norgauer, J.; Aktories, K. 1994: ADP-ribosylation of the GTP-binding protein Rho by Clostridium limosum exoenzyme affects basal, but not N-formyl-peptide-stimulated, actin polymerization in human myeloid leukaemic (HL60) cells. Biochemical Journal 299: 775-779

Aepfelbacher, M.; Essler, M.; Luber De Quintana, K.; Weber, P.C. 1995: ADP-ribosylation of the GTP-binding protein RhoA blocks cytoplasmic division in human myelomonocytic cells. Biochemical Journal 308: 853-858

Ledford, B.E.; Leno, G.H. 1994: ADP-ribosylation of the molecular chaperone GRP78/BiP. Molecular and Cellular Biochemistry 138(1-2): 141-148

Coggins, P.J.; Mclean, K.; Nagy, A.; Zwiers, H. 1993: ADP-ribosylation of the neuronal phosphoprotein B-50/GAP-43. Journal of Neurochemistry 60(1): 368-371

Yamamoto, M.; Marui, N.; Sakai, T.; Morii, N.; Kozaki, S.; Ikai, K.; Imamura, S.; Narumiya, S. 1993: ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 8(6): 1449-1455

Terashima, M.; Hara, N.; Badruzzaman, M.; Shimoyama, M.; Tsuchiya, M. 1997: ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages. Febs Letters 412(1): 227-232

Wesierska-Gadek, J.; Schmid, G.; Cerni, C. 1996: ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochemical and Biophysical Research Communications 224(1): 96-102

O'Farrell, M. 1995: ADP-ribosylation reactions in plants. Biochimie 77(6): 486-491

Faraone-Mennella, M.R.; De Lucia, F.; De Maio, A.; Gambacorta, A.; Quesada, P.; De Rosa, M.; Nicolaus, B.; Farina, B. 1995: ADP-ribosylation reactions in Sulfolobus solfataricus, a thermoacidophilic archaeon. Biochimica Et Biophysica Acta 1246(2): 151-159

Morgan, C.P.; Sengelov, H.; Whatmore, J.; Borregaard, N.; Cockcroft, S. 1997: ADP-ribosylation-factor-regulated phospholipase D activity localizes to secretory vesicles and mobilizes to the plasma membrane following N-formylmethionyl-leucyl-phenylalanine stimulation of human neutrophils. Biochemical Journal 325: 581-585

Boulias, C.; Mastronardi, F.G.; Moscarello, M.A. 1995: ADP-ribosyltransferase activity in myelin membranes isolated from human brain. Neurochemical Research 20(11): 1269-1277

Vickers, J.D. 1993: ADP-stimulated fibrinogen binding is necessary for some of the inositol phospholipid changes found in ADP-stimulated platelets. European Journal of Biochemistry 216(1): 231-237

Kato, M.; Yang, J.; Hattori, H.; Iwai, T.; Miyairi, M.; Takeda, N.; Nagano, M. 1993: ADP/ATP carrier protein in cardiomyopathic hamster and the changes of mitochondrial enzyme activity in swimming training rats. Bulletin of the Physical Fitness Research Institute 1993(83): 36-44

Schunemann, D..; Borchert, S..; Flugge, U.. I..; Heldt, H.. W.. 1993: ADP/ATP Translocator from Pea Root Plastids (Comparison with Translocators from Spinach Chloroplasts and Pea Leaf Mitochondria). Plant Physiology 103(1): 131-137

Faraone-Mennella, M.R.; De Lucia, F.; De Maio, A.; Gambacorta, A.; Nicolaus, B.; Farina, B. 1997: ADPribosylation reaction by free ADPribose in Sulfolobus solfataricus, a thermophilic archaeon. Journal of Cellular Biochemistry 66(1): 37-42

Egberts, A.C.; de Koning, F.H.; Meyboom, R.H.; Leufkens, H.G. 1997: ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs. Pharmacoepidemiology and Drug Safety 6(4): 269-276

Chiang, Y.C.; Komarnitsky, P.; Chase, D.; Denis, C.L. 1996: ADR1 activation domains contact the histone acetyltransferase GCN5 and the core transcriptional factor TFIIB. Journal of Biological Chemistry 271(50): 32359-32365

Navarro, B.; Igual, J.C. 1994: ADR1 and SNF1 mediate different mechanisms in transcriptional regulation of yeast POT1 gene. Biochemical and Biophysical Research Communications 202(2): 960-966

Komarnitsky, P.B.; Klebanow, E.R.; Weil, P.A.; Denis, C.L. 1998: ADR1-mediated transcriptional activation requires the presence of an intact TFIID complex. Molecular and Cellular Biology 18(10): 5861-5867

Torelli, A.; Robotti, C.A. 1994: ADVANCE and ADAM: two algorithms for the analysis of global similarity between homologous informational sequences. Computer Applications in the Biosciences: Cabios 10(1): 3-5

Kluettgen, B.; Duelmer, U.; Engels, M.; Ratte, H.T. 1994: ADaM, an artificial freshwater for the culture of zooplankton. Water Research 28(3): 743-746

Yamanaga, K.; Shinyama, H.; Akira, T.; Iwamoto, M.; Uchida, T.; Nakamura, N.; Kagitani, Y. 1997: AE0047-mediated calcium channel blocking in vascular smooth muscles. General Pharmacology 29(3): 337-343

Kobayashi, S.; Morgans, C.W.; Casey, J.R.; Kopito, R.R. 1994: AE3 anion exchanger isoforms in the vertebrate retina: developmental regulation and differential expression in neurons and glia. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(10): 6266-6279

Engel, T.; Hoogenboom, G.; Jones, J.W.; Wilkens, P.W. 1997: AEGIS/WIn: A computer program for the application of crop stimulation models across geographic areas. Agronomy Journal 89(6): 919-928

Holben, B.N.; Eck, T.F.; Slutsker, I.; Tanre, D.; Buis, J.P.; Setzer, A.; Vermote, E.; Reagen, J.A.; Kaufman, Y.J.; Nakajima, T.; Lavenu, F.; Jankowiak, I.; Smirnov, A. 1998: AERONET: A federated instrument network and data archive for aerosol characterization. Remote Sensing of Environment 66(1): 1-16

Laurent, J.P.; Baribeau, J. 1992: AERPs and clinical evolution of thought disorders over five years. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 13(3): 271-282

Cantrell, R. 1998: AF and PA's Sustainable Forestry Initiative: A bold new program that works for the U.S.A. Biomass and Bioenergy 14(4): 325-328

Henttu, P.M.; Kalkhoven, E.; Parker, M.G. 1997: AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Molecular and Cellular Biology 17(4): 1832-1839

Dopke, K.L.; Vrana, K.E.; Vogt, L.J.; Vogt, B.A. 1995: AF-DX 384 binding in rabbit cingulate cortex: two site kinetics and section autoradiography. Journal of Pharmacology and Experimental Therapeutics 274(1): 562-569

Tanabe, S.; Bohlander, S.K.; Vignon, C.V.; Espinosa, R.; Zhao, N.; Strissel, P.L.; Zeleznik-Le, N.J.; Rowley, J.D. 1996: AF10 is split by MLL and HEAB, a human homolog to a putative Caenorhabditis elegans ATP/GTP-binding protein in an invins(10;11)(p12;q23q12). Blood 88(9): 3535-3545

Vincent, G.P.; Sepinwall, J. 1992: AF102B, a novel M1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of action. Brain Research 597(2): 264-268

Akeson, A.L.; Woods, C.W.; Hsieh, L.C.; Bohnke, R.A.; Ackermann, B.L.; Chan, K.Y.; Robinson, J.L.; Yanofsky, S.D.; Jacobs, J.W.; Barrett, R.W.; Bowlin, T.L. 1996: AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. Journal of Biological Chemistry 271(48): 30517-30523

Brandeis, R.; Sapir, M.; Hafif, N.; Abraham, S.; Oz, N.; Stein, E.; Fisher, A. 1995: AF150(S): a new functionally selective M1 agonist improves cognitive performance in rats. Pharmacology Biochemistry and Behavior 51(4): 667-674

Frestedt, J.L.; Hilden, J.M.; Kersey, J.H. 1996: AF4/FEL, a gene involved in infant leukemia: Sequence variations, gene structure, and possible homology with a genomic sequence on 5q31. DNA and Cell Biology 15(8): 669-678

Saha, V.; Lillington, D.M.; Shelling, A.N.; Chaplin, T.; Yaspo, M.L.; Ganesan, T.S.; Young, B.D. 1995: AF6 gene on chromosome band 6q27 maps distal to the minimal region of deletion in epithelial ovarian cancer. Genes Chromosomes and Cancer 14(3): 220-222

Opello, K.D.; Stackman, R.W.; Ackerman, S.; Walsh, T.J. 1993: AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: relation to cholinergic hypofunction. Physiology and Behavior 54(6): 1227-1233

Dong, X.W.; Hanin, I.; Lorens, S.A. 1994: AF64A affects septal choline acetyltransferase but not parvalbumin immunoreactive cells. Brain Research Bulletin 35(3): 217-220

Murai, S.; Saito, H.; Masuda, Y.; Odashima, J.; Itoh, T. 1995: AF64A disrupts retrieval processes in long-term memory of mice. Neuroreport 6(2): 349-352

Zhou, L.W.; Zhang, S.P.; Connell, T.A.; Weiss, B. 1993: AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists. Journal of Pharmacology and Experimental Therapeutics 264(2): 824-830

Santiago, L.R.; Erickson, L.C.; Hanin, I. 1998: AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3. Neurochemical Research 23(5): 743-750

Santiago, L.R.; Ivy, M.T.; Erickson, L.C.; Hanin, I. 1995: AF64A-induced cytotoxicity and changes in choline acetyltransferase activity in the LA-N-2 neuroblastoma cell line are modulated by choline and hemicholinium-3. Journal of Neuroscience Methods 61(1-2): 185-190

Hillion, J.; Le Coniat, M.; Jonveaux, P.; Berger, R.; Bernard, O.A. 1997: AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90(9): 3714-3719

Cowden, C.; Stretton, A.O. 1993: AF2, an Ascaris neuropeptide: isolation, sequence, and bioactivity. Peptides 14(3): 423-430

Lee, Y.J.; Wickner, R.B. 1992: AFG1, a new member of the SEC18-NSF, PAS1, CDC48-VCP, TBP family of ATPases. Yeast 8(9): 787-790

Thorsness, P.E.; White, K.H.; Ong, W.C. 1993: AFG2, an essential gene in yeast, encodes a new member of the Sec18p, Pas1p, Cdc48p, TBP-1 family of putative ATPases. Yeast 9(11): 1267-1271

Ji, R.R.; Zhang, Q.; Pettersson, R.F.; Hökfelt, T. 1996: AFGF, bFGF and NGF differentially regulate neuropeptide expression in dorsal root ganglia after axotomy and induce autotomy. Regulatory Peptides 66(3): 179-189

Bugra, K.; Pollard, H.; Charton, G.; Moreau, J.; Ben-Ari, Y.; Khrestchatisky, M. 1994: AFGF, bFGF and flg mRNAs show distinct patterns of induction in the hippocampus following kainate-induced seizures. European Journal of Neuroscience 6(1): 58-66

Sharma, S.K.; Knox, M.R.; Ellis, T.H. 1996: AFLP analysis of the diversity and phylogeny of Lens and its comparison with RAPD analysis. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 93(5-6): 751-758

Suh, Y.; Kim, S.; Park, C.-Wook 1997: AFLP examination for putative hybrids between Aconitum japonicum ssp. napiforme and A. jaluense (Ranunculaceae). Korean Journal of Plant Taxonomy 27(1): 59-71

Cervera, M.T.; Storme, V.; Liu, B.; Gusmao, J.; Steenackers, M.; Ivens, B.; Michiels, B.; Van Montagu, M.; Boerjan, W. 1997: AFLP genome mapping of polar. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 62(4A-B): 1435-1441

Sloos, J.H.; Janssen, P.; van Boven, C.P.; Dijkshoorn, L. 1998: AFLP typing of Staphylococcus epidermidis in multiple sequential blood cultures. Research in Microbiology 149(3): 221-228

Allen, M.J.; Bradbury, E.M.; Balhorn, R. 1997: AFM analysis of DNA-protamine complexes bound to mica. Nucleic Acids Research 25(11): 2221-2226

Rotsch, C.; Braet, F.; Wisse, E.; Radmacher, M. 1997: AFM imaging and elasticity measurements on living rat liver macrophages. Cell Biology International 21(11): 685-696

Ohnesorge, F.M.; Hörber, J.K.; Häberle, W.; Czerny, C.P.; Smith, D.P.; Binnig, G. 1997: AFM review study on pox viruses and living cells. Biophysical Journal 73(4): 2183-2194

Tillmann, R.W.; Hofmann, U.G.; Gaub, H.E. 1994: AFM-Investigation of the molecular structure of films from a polymerizable two-chain lipid. Chemistry and Physics of Lipids 73(1-2): 81-89

Cox, R.W. 1996: AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research An International Journal 29(3): 162-173

Bassetto, M.A.; Franceschi, T.; Lenotti, M.; Parise, G.; Pancheri, F.; Sabbioni, R.; Zaninelli, M.; Cetto, G.L. 1994: AFP and HCG in germ cell tumors. International Journal of Biological Markers 9(1): 29-32

Lamerz, R. 1997: AFP isoforms and their clinical significance (overview). Anticancer Research 17(4b): 2927-2930

Asamura, H.; Nakayama, H.; Kondo, H.; Tsuchiya, R.; Ono, R.; Noguchi, M.; Yoda, H.; Naruke, T. 1996: AFP-producing squamous cell carcinoma of the lung in an adolescent. Japanese Journal of Clinical Oncology 26(2): 103-106

Konopka, J.B. 1993: AFR1 acts in conjunction with the alpha-factor receptor to promote morphogenesis and adaptation. Molecular and Cellular Biology 13(11): 6876-6888

Konopka, J.B.; DeMattei, C.; Davis, C. 1995: AFR1 promotes polarized apical morphogenesis in Saccharomyces cerevisiae. Molecular and Cellular Biology 15(2): 723-730

Yamaguchi-Iwai, Y.; Dancis, A.; Klausner, R.D. 1995: AFT1: a mediator of iron regulated transcriptional control in Saccharomyces cerevisiae. EMBO Journal 14(6): 1231-1239

Peters, U.; Haberhausen, G.; Kostrzewa, M.; Nolte, D.; Müller, U. 1997: AFX1 and p54nrb: fine mapping, genomic structure, and exclusion as candidate genes of X-linked dystonia parkinsonism. Human Genetics 100(5-6): 569-572

Nunoi, H.; Iwata, M.; Tatsuzawa, S.; Onoe, Y.; Shimizu, S.; Kanegasaki, S.; Matsuda, I. 1995: AG dinucleotide insertion in a patient with chronic granulomatous disease lacking cytosolic 67-kD protein. Blood 86(1): 329-333

Boritzki, T.J.; Barlett, C.A.; Zhang, C.; Howland, E.F. 1996: AG2034: A novel inhibitor of glycinamide ribonucleotide formyltransferase. Investigational New Drugs 14(3): 295-303

Webber, S.; Bartlett, C.A.; Boritzki, T.J.; Hillard, J.A.; Howland, E.F.; Johnston, A.L.; Kosa, M.; Margosiak, S.A.; Morse, C.A.; Shetty, B.V. 1996: AG337, a novel lipophilic thymidylate synthase inhibitor: In vitro and in vivo preclinical studies. Cancer Chemotherapy and Pharmacology 37(6): 509-517

Sestili, P.; Guidarelli, A.; Cattabeni, F.; Murray, D.; Cantoni, O. 1996: AG8 cells, which are highly resistant to hydrogen peroxide, display collateral sensitivity to the combination of hydrogen peroxide and L-histidine. Carcinogenesis 17(4): 885-888

Bierhaus, A.; Hofmann, M.A.; Ziegler, R.; Nawroth, P.P. 1998: AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular Research 37(3): 586-600

Thomson, G. 1993: AGFAP method: applicability under different ascertainment schemes and a parental contributions test. Genetic Epidemiology 10(5): 289-310

Parker, G.F.; Roberts, D.B. 1996: AGI, a previously unreported D. melanogaster alpha-glucosidase: partial purification, characterization, and cytogenetic mapping. Biochemical Genetics 34(3-4): 117-131

Takamiya, Y.; Brem, H.; Ojeifo, J.; Mineta, T.; Martuza, R.L. 1994: AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery 34(5): 869

Antoine, N.; Greimers, R.; De Roanne, C.; Kusaka, M.; Heinen, E.; Simar, L.J.; Castronovo, V. 1994: AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Research 54(8): 2073-2076

Agarwal, C.; Chandraratna, R.A.; Johnson, A.T.; Rorke, E.A.; Eckert, R.L. 1996: AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. Journal of Biological Chemistry 271(21): 12209-12212

Symonds, D.A.; Reed, T.P.; Didolkar, S.M.; Graham, R.R. 1997: AGUS in cervical endometriosis. Journal of Reproductive Medicine 42(1): 39-43

Datta, K.; Franke, T.F.; Chan, T.O.; Makris, A.; Yang, S.I.; Kaplan, D.R.; Morrison, D.K.; Golemis, E.A.; Tsichlis, P.N. 1995: AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Molecular and Cellular Biology 15(4): 2304-2310

McCabe, R.T.; Newman, A.H.; Skolnick, P. 1992: AHN 683: a fluorescent ligand for peripheral-type benzodiazepine receptors. Journal of Pharmacology and Experimental Therapeutics 262(2): 734-740

Kubat, M.; Pfurtscheller, G.; Flotzinger, D. 1994: AI-based approach to automatic sleep classification. Biological Cybernetics 70(5): 443-448

Bridges, A.J.; Reid, J.C.; Cutts, J.H.; Hazelwood, S.; Sharp, G.C.; Mitchell, J.A. 1993: AI/LEARN/Rheumatology. A comparative study of computer-assisted instruction for rheumatology. Arthritis and Rheumatism 36(5): 577-580

Anzick, S.L.; Kononen, J.; Walker, R.L.; Azorsa, D.O.; Tanner, M.M.; Guan, X.Y.; Sauter, G.; Kallioniemi, O.P.; Trent, J.M.; Meltzer, P.S. 1997: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277(5328): 965-968

Anderson, D.R.; Burnham, K.P. 1994: AIC model selection in overdispersed capture-recapture data. Ecology 75(6): 1780-1793

Hori, M.; Kitakaze, M.; Takashima, S.; Morioka, T.; Sato, H.; Minamino, T.; Node, K.; Komamura, K.; Inoue, M.; Kamada, T. 1994: AICA riboside improves myocardial ischemia in coronary microembolization in dogs. American Journal of Physiology 267(4 Pt 2): H1483-H1495

Fox, M.; Frandsen, N.; D'ari, R. 1993: AICAR is not an endogenous mutagen in Escherichia coli. Molecular and General Genetics: Mgg 240(3): 355-359

Hamann, J.; Montgomery, K.T.; Lau, S.; Kucherlapati, R.; van Lier, R.A. 1997: AICL: A new activation-induced antigen encoded by the human NK gene complex. Immunogenetics 45(5): 295-300

Lehmann, E.D.; Deutsch, T. 1993: AIDA2: a Mk. II automated insulin dosage advisor. Journal of Biomedical Engineering 15(3): 201-211

Lehmann, E.D.; Deutsch, T.; Carson, E.R.; Sönksen, P.H. 1994: AIDA: an interactive diabetes advisor. Computer Methods and Programs in Biomedicine 41(3-4): 183-203

Dattel, B.J.; Darney, P.D.; Hauer, L.B.; Crombleholme, W.R.; Sweet, R.L. 1992: AIDS (HIV) risk assessment in an inner-city women's clinic. Journal of Reproductive Medicine 37(9): 821-825

Lebow, J.M.; O'Connell, J.J.; Oddleifson, S.; Gallagher, K.M.; Seage, G.R.; Freedberg, K.A. 1995: AIDS among the homeless of Boston: a cohort study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 8(3): 292-296

Barker, P.B.; Lee, R.R.; McArthur, J.C. 1995: AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 195(1): 58-64

Cote, T., R.; O'brien, T., R.; Ward, J., W.; Wilson, S., E.; Blattner, W., A.; Group, T.-National-Aids-Cancer-Match-Study 1995: AIDS and Cancer Registry Linkage: Measurement and Enhancement of Registry Completeness. Preventive Medicine 24(4): 375-377

Wirawan, D.N.; Fajans, P.; Ford, K. 1993: AIDS and STDs: risk behaviour patterns among female sex workers in Bali, Indonesia. Aids Care 5(3): 289-303

Briole, G.; Gautier, D.; Lafont, B. 1996: AIDS and TSSE, a new challenge for the turn of this century: Considerations on psychological and psychosocial aspects of transmitted subacute spongiform encephalopathies. Medecine et Armees 24(8): 639-642

Cannon, W.D.; Vittori, J.M. 1992: AIDS and arthroscopic surgery. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 8(3): 279-286

Pinto, A.N. 1996: AIDS and cerebrovascular disease. Stroke 27(3): 538-543

Daisley, H.; Swanston, W.; Hutchinson, G.; Charles, W.; Simmons, V. 1997: AIDS and cocaine addiction. Review and research findings. Research Communications in Alcohol and Substances of Abuse 18(3-4): 81-92

Green, G. 1995: AIDS and euthanasia. Aids Care 7(Suppl. 2): S169-S173

Deutsch, E. 1993: AIDS and hemophilia in France and Germany. AIDS-Forschung 8(3): 153-160

Buvé, A. 1997: AIDS and hospital bed occupancy: an overview. Tropical Medicine and International Health: Tm and Ih 2(2): 136-139

ter Horst, G. 1993: AIDS and infection control: Dutch dental hygienists surveyed. Community Dentistry and Oral Epidemiology 21(2): 86-90

Carvajal, M.J.; Vicioso, C.; Santamaria, J.M.; Bosco, A. 1995: AIDS and suicide issues in Spain. Aids Care 7 Suppl. 2: S135-S138

Slonim, C.B. 1995: AIDS and the contact lens practice. Clao Journal: Official Publication of the Contact Lens Association of Ophthalmologists Inc 21(4): 233-235

Bayer, R.; Fairchild-Carrino, A. 1993: AIDS and the limits of control: public health orders, quarantine, and recalcitrant behavior. American Journal of Public Health 83(10): 1471-1476

Viza, D. 1996: AIDS and transfer factor: myths, certainties and realities. BioTherapy 9(1-3): 17-26

Fanelli, M.; Fontana, A.; Sanguedolce, A.; Troiano, T.; Quarto, M.; Serio, G. 1994: AIDS and young people: Results of a survey in the school. Igiene Moderna 101(3): 289-312

Tovo, P.A.; de Martino, M.; Gabiano, C.; Galli, L.; Tibaldi, C.; Vierucci, A.; Veglia, F. 1994: AIDS appearance in children is associated with the velocity of disease progression in their mothers. Journal of Infectious Diseases 170(4): 1000-1002

Sweat, M.D.; Nopkesorn, T.; Mastro, T.D.; Sangkharomya, S.; MacQueen, K.; Pokapanichwong, W.; Sawaengdee, Y.; Weniger, B.G. 1995: AIDS awareness among a cohort of young Thai men: exposure to information, level of knowledge, and perception of risk. Aids Care 7(5): 573-591

Kumar, A.; Lal, P.; Walia, M.; Arora, R.; Gulati, N. 1996: AIDS awareness among nursing students of Delhi. Journal of Communicable Diseases 28(1): 20-27

Kolson, D.L..; Pomerantz, R.J.. 1996: AIDS Dementia and HIV-1-Induced Neurotoxicity: Possible Pathogenic Associations and Mechanisms. Journal of Biomedical Science 3(6): 389-414

Brew, B.J.; Rosenblum, M.; Cronin, K.; Price, R.W. 1995: AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Annals of Neurology 38(4): 563-570

Fiala, M.; Singer, E.J.; Graves, M.C.; Tourtellotte, W.W.; Stewart, J.A.; Schable, C.A.; Rhodes, R.H.; Vinters, H.V. 1993: AIDS dementia complex complicated by cytomegalovirus encephalopathy. Journal of Neurology 240(4): 223-231

Chiesi, A.; Seeber, A.C.; Dally, L.G.; Floridia, M.; Rezza, G.; Vella, S. 1996: AIDS dementia complex in the Italian National AIDS Registry: Temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection. Journal of the Neurological Sciences 144(1-2): 107-113

Portegies, P. 1994: AIDS dementia complex: a review. Journal of Acquired Immune Deficiency Syndromes 7(Suppl 2): S38

Grassi, M.P.; Perin, C.; Borella, M.; Mangoni, A. 1997: AIDS dementia complex: Clinical and neuropsychological aspects. Giornale Italiano di Malattie Infettive 3(3): 136-145

Nuovo, G.J.; Alfieri, M.L. 1996: AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Molecular Medicine 2(3): 358-366

el-Mallakh, R.S. 1992: AIDS dementia-related psychosis: is there a window of vulnerability?. Aids Care 4(4): 381-387

Santana, R.T.; Monzon, O.T.; Mandel, J.; Hall, T.L.; Hearst, N. 1992: AIDS education for hospital workers in Manila: effects on knowledge, attitudes, and infection control practices. Aids 6(11): 1359-1363

Klepp, K.I.; Ndeki, S.S.; Seha, A.M.; Hannan, P.; Lyimo, B.A.; Msuya, M.H.; Irema, M.N.; Schreiner, A. 1994: AIDS education for primary school children in Tanzania: an evaluation study. Aids 8(8): 1157-1162

Bartlett, J.G.; Belitsos, P.C.; Sears, C.L. 1992: AIDS enteropathy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 15(4): 726-735

Lwihula, G.; Dahlgren, L.; Killewo, J.; Sandström, A. 1993: AIDS epidemic in Kagera region, Tanzania--the experiences of local people. Aids Care 5(3): 347-357

Katz, M.H. 1997: AIDS epidemic in San Francisco among men who report sex with men: successes and challenges of HIV prevention. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 14(Suppl): S38-S46

Papadopulos-Eleopulos, E.; Turner, V.F.; Papadimitriou, J.M.; Bialy, H. 1995: AIDS in Africa: distinguishing fact and fiction. World Journal of Microbiology and Biotechnology 11(2): 135-143

O'Farrell, N.; Lau, R.; Yoganathan, K.; Bradbeer, C.S.; Griffin, G.E.; Pozniak, A.L. 1995: AIDS in Africans living in London. Genitourinary Medicine 71(6): 358-362

Garavelli, P.L. 1995: AIDS in Alessandria district. Archivio di Medicina Interna 47(1): 13-16

Potterat, J.J.; Woodhouse, D.E.; Rothenberg, R.B.; Muth, S.Q.; Darrow, W.W.; Muth, J.B.; Reynolds, J.U. 1993: AIDS in Colorado Springs: is there an epidemic?. Aids 7(11): 1517-1521

Pape, J.; Johnson, W.D. 1993: AIDS in Haiti: 1982-1992. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 17(Suppl): S341-S345

Comiskey, C.M.; Ruskin, H.J. 1992: AIDS in Ireland: the reporting delay distribution and the implementation of integral equation models. Computer Applications in the Biosciences: Cabios 8(6): 579-581

Dal Maso, J.; Grella, P.V. 1994: AIDS in Italy and proposals for a new therapeutic strategy. Clinical and Experimental Obstetrics and Gynecology 21(4): 231-242

Lazard, T.; Retel, O.; Guidet, B.; Maury, E.; Valleron, A.J.; Offenstadt, G. 1996: AIDS in a medical intensive care unit: immediate prognosis and long-term survival. JAMA 276(15): 1240-1245

Coulaud, J.P.; Lariven, S. 1995: AIDS in adolescents (epidemiology and prevention). Contraception Fertilite Sexualite 23(2): 131-136

Rigardetto, R.; Arfelli, P.; Barbicinti, I.; Boffi, P.; Bonassi, E.; Cavallo, P.; Ferrario, M.R.; Gandione, M.; Genta, M. 1993: AIDS in evolutive age: Chronic and mortal illness. Giornale di Neuropsichiatria dell'Eta Evolutiva 13(1): 19-35

Hirata, S.; Watanabe, M.; Katsuno, S. 1995: AIDS in the Japanese Mass Media: Content Analysis of Articles about AIDS from 1982 to 1992 in the Japanese Newspaper. Japanese Journal of Health and Human Ecology 61(1): 2-15

Chuang, C.Y.; Chang, P.Y.; Lin, K.C. 1993: AIDS in the Republic of China, 1992. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 17(Suppl): S337-S340

Berkely, S. 1993: AIDS in the developing world: an epidemiologic overview. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 17(Suppl 2): S329-S336

Gaeta, T.J.; LaPolla, C.; Melendez, E. 1996: AIDS in the elderly: New York City vital statistics. Journal of Emergency Medicine 14(1): 19-23

Wortley, P.M.; Fleming, P.L. 1997: AIDS in women in the United States. Recent trends. JAMA 278(11): 911-916

Fife, D.; Mode, C. 1992: AIDS incidence and income. Journal of Acquired Immune Deficiency Syndromes 5(11): 1105-1110

Longo, G.; Chaves, G.; Valicenti, P., A.; Torino, M., L.; Huberman, E., D. 1992: AIDS incidence in a General Hospital from Argentina (1990-1991). Prensa Medica Argentina 79(9): 564-569

Franceschi, S.; Dal Maso, L.; La Vecchia, C.; Negri, E.; Serraino, D. 1994: AIDS incidence rates in Europe and the United States. Aids 8(8): 1173-1177

Fergusson, D.M.; Lynskey, M.T.; Horwood, L.J. 1994: AIDS knowledge and condom use in a birth cohort of 16 year olds. New Zealand Medical Journal 107(990): 480-483

Kramer, T.H.; Nelson, D.F.; Li, P.W. 1993: AIDS knowledge and risk behaviours among traumatic brain injury survivors with coexisting substance abuse. Brain Injury 7(3): 209-217

Aruffo, J.F.; Coverdale, J.H.; Pavlik, V.N.; Vallbona, C. 1993: AIDS knowledge in minorities: significance of locus of control. American Journal of Preventive Medicine 9(1): 15-20

Ford, K.; Wirawan, D.N.; Fajans, P. 1995: AIDS knowledge, risk behaviors, and condom use among four groups of female sex workers in Bali, Indonesia. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 10(5): 569-576

Ford, K.; Wirawan, D.N.; Fajans, P.; Thorpe, L. 1995: AIDS knowledge, risk behaviors, and factors related to condom use among male commercial sex workers and male tourist clients in Bali, Indonesia. Aids 9(7): 751-759

Ryder, R.W.; Kamenga, M.; Nkusu, M.; Batter, V.; Heyward, W.L. 1994: AIDS orphans in Kinshasa, Zaïre: incidence and socioeconomic consequences. AIDS 8(5): 673-679

Walewska-Zielecka, B.; Kamiński, Z.; Nowosławski, A. 1996: AIDS pathology: infections and neoplasms in 55 fatal AIDS cases. A postmortem study. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 47(4): 163-170

Dudhane, A.; Wang, Z.Q.; Orlikowsky, T.; Gupta, A.; Wormser, G.P.; Horowitz, H.; Kufer, P.; Hoffmann, M.K. 1996: AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules. Aids Research and Human Retroviruses 12(10): 893-899

Mariner, W.K. 1995: AIDS phobia, public health warnings, and lawsuits: deterring harm or rewarding ignorance?. American Journal of Public Health 85(11): 1562-1568

Medvedeva, S.B. 1993: AIDS phobia: Clinical issues and typology. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova 93(6): 73-76

Yonemoto, S. 1997: AIDS policy in Japan: integration within structured paternalism. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 14(Suppl): S17-S21

Bass, P.S.; Garrett, P.J.; Ellison, D.W.; Terry, P.; O'Connell, S.; Theaker, J.M.; Dathan, J.R.; Fine, D. 1994: AIDS presenting as focal segmental membranous glomerulopathy. Journal of Clinical Pathology 47(2): 179-181

Singer, E.J.; Stoner, G.L.; Singer, P.; Tomiyasu, U.; Licht, E.; Fahy-Chandon, B.; Tourtellotte, W.W. 1994: AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine. Acta Neurologica Scandinavica 90(6): 443-447

Vadillo, M.; Corbella, X.; Carratala, J. 1994: AIDS presenting as septic shock caused by Mycobacterium tuberculosis. Scandinavian Journal of Infectious Diseases 26(1): 105-106

Fife, D.; Mode, C. 1992: AIDS prevalence by income group in Philadelphia. Journal of Acquired Immune Deficiency Syndromes 5(11): 1111-1115

Moreau Gruet, F.; Dubois Arber, F. 1996: AIDS prevention among homosexuals in Switzerland: Modes of adaptation to risk according to type of partner. Sozial- und Praeventivmedizin 41(1): 1-10

Schaller, G.; Harding, T.W. 1995: AIDS prevention in European prisons. Sozial- und Praventivmedizin 40(5): 298-301

Pick, S.; Reyes, J.; Alvarez, M.; Cohen, S.; Craige, J.; Troya, A. 1996: AIDS prevention training for pharmacy workers in Mexico City. Aids Care 8(1): 55-69

de Wolf, F.; Spijkerman, I.; Schellekens, P.T.; Langendam, M.; Kuiken, C.; Bakker, M.; Roos, M.; Coutinho, R.; Miedema, F.; Goudsmit, J. 1997: AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. Aids 11(15): 1799-1806

London, L. 1996: AIDS programmes at the workplace: a scoresheet for assessing the quality of services. Occupational Medicine 46(3): 216-220

Carducci, A.; Frasca, M.; Grasso, A.; Terzi, I.; Avio, C.M. 1995: AIDS related information, attitudes and behaviours among Italian male young people. European Journal of Epidemiology 11(1): 23-31

Gabutti, G.; Vercelli, M.; De Rosa, M.G.; Orengo, M.A.; Casella, C.; Garrone, E.; Orlandini, C.; Piersantelli, N.; Torresin, A.; Rizzo, F. 1995: AIDS related neoplasms in Genoa, Italy. European Journal of Epidemiology 11(6): 609-614

Joffe, H. 1996: AIDS research and prevention: A social representational approach. British Journal of Medical Psychology 69: 169-190

Stall, R.; Catania, J. 1994: AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral Surveys. Archives of Internal Medicine 154(1): 57-63

Fitterling, J.M.; Matens, P.B.; Scotti, J.R.; Allen, J.S. 1993: AIDS risk behaviors and knowledge among heterosexual alcoholics and non-injecting drug users. Addiction 88(9): 1257-1265

Maxwell, A.E.; Bastani, R.; Yan, K.X. 1995: AIDS risk behaviours and correlates in teenagers attending sexually transmitted diseases clinics in Los Angeles. Genitourinary Medicine 71(2): 82-87

Walter, H.J.; Vaughan, R.D. 1993: AIDS risk reduction among a multiethnic sample of urban high school students. JAMA 270(6): 725-730

Hughes, V.; Stall, R.D.; Klouri, C.; Barrett, D.C.; Arevalo, E.I.; Hearst, N. 1995: AIDS risk-taking behavior during carnival in São Paulo, Brazil. Aids 9(Suppl): S39-S44

Ansovini, R.; Barbolini, G.; Migaldi, M.; Botticelli, L.; De Rienzo, B. 1998: AIDS splenomegaly and related ferric iron storage. Pathologica (Genoa) 90(2): 133-139

Anonymous 1994: AIDS surveillance in Europe: Status at 30th June 1993. Sozial-undPraventivmedizin 39(3): 179

Anonymous 1993: AIDS surveillance in Europe: Status at 31st December 1992. Sozial- und Praventivmedizin 38(4): 249-250

Hickman, M.; Aldous, J.; Gazzard, B.; Ellam, A. 1993: AIDS surveillance: a direct assessment of under-reporting. Aids 7(12): 1661-1665

Low, N.; Paine, K.; Clark, R.; Mahalingam, M.; Pozniak, A.L. 1996: AIDS survival and progression in black Africans living in south London, 1986-1994. Genitourinary Medicine 72(1): 12-16

Mathé, G.; Pontiggia, P.; Orbach-Arbouys, S.; Triana, K.; Ambetima, N.; Morette, C.; Hallard, M.; Blanquet, D. 1996: AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. first of two parts: a phase i trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue. Biomedicine and PharmacoTherapy 50(5): 220-227

Csere, P.; Varbiro, G.; Sumegi, B.; Mozsik, G. 1997: AIDS treatment and the heat shock protein level in the gastrointestinal tract. Gaginella, T. S. , Mozsik, G. , Rainsford, K. D. Biochemical Pharmacology As An Approach To Gastrointestinal Disorders: Basic Science To Clinical Perspectives (1996). 287-295

Diaz, T.; Buehler, J.W.; Castro, K.G.; Ward, J.W. 1993: AIDS trends among Hispanics in the United States. American Journal of Public Health 83(4): 504-509

Chiarantini, L.; Matteucci, D.; Pistello, M.; Mancini, U.; Mazzetti, P.; Massi, C.; Giannecchini, S.; Lonetti, I.; Magnani, M.; Bendinelli, M. 1998: AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens. Clinical and Diagnostic Laboratory Immunology 5(2): 235-241

Pivnick, A.; Jacobson, A.; Eric, K.; Doll, L.; Drucker, E. 1994: AIDS, HIV infection, and illicit drug use within inner-city families and social networks. American Journal of Public Health 84(2): 271-274

Healy, E.; Kelly, P.; Mulcahy, F.M.; Clancy, L. 1992: AIDS, i.v. drug use and mycobacterial disease: the Dublin experience. Respiratory Medicine 86(6): 491-494

Wittmann, M.M.; Wittmann, A.; Wittmann, D.H. 1996: AIDS, emergency operations, and infection control. Infection Control and Hospital Epidemiology 17(8): 532-538

Van Den Boom, F. 1995: AIDS, euthanasia and grief. Aids Care 7(Suppl): 5175-5185

Duffin, J. 1994: AIDS, memory and the history of medicine: musings on the Canadian response. Genitourinary Medicine 70(1): 64-69

Marquez, M.; Verde, C. 1996: AIDS, prevention and suitable practice. Prensa Medica Argentina 83(3): 263-266

Shibata, K.; Sasaki, T.; Watanabe, T. 1995: AIDS-associated mycoplasmas possess phospholipases C in the membrane. Infection and Immunity 63(10): 4174-4177

Carbone, A.; Gloghini, A.; Gaidano, G.; Cilia, A.M.; Bassi, P.; Polito, P.; Vaccher, E.; Saglio, G.; Tirelli, U. 1995: AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. American Journal of Clinical Pathology 103(5): 561-567

Serraino, D.; Franceschi, S.; Greco, D.; Carbone, A.; Monfardini, S.; Tirelli, U. 1994: AIDS-associated Kaposi's sarcoma and non-Hodgkin's lymphomas reporting in Italy: a linkage study. Journal of Acquired Immune Deficiency Syndromes 7(11): 1202-1207

Weeks, B.S.; Cooney, R. 1997: AIDS-associated Kaposi's sarcoma cells secrete a neurotrophic growth factor(s). Biochemical and Biophysical Research Communications 233(2): 408-412

Orlow, S.J.; Cooper, D.; Petrea, S.; Kamino, H.; Popescu, V.; Lawrence, R.; Leibovitz, E. 1993: AIDS-associated Kaposi's sarcoma in Romanian children. Journal of the American Academy of Dermatology 28(3): 449-453

Bhoopat, S.K.; Vithayasai, P.; Pruksachatkunakorn, C. 1996: AIDS--associated Kaposi's sarcoma: a rare entity at Maharaj Nakorn Chiang Mai Hospital. Asian Pacific Journal of Allergy and Immunology 14(2): 115-120

Castiella, A.; Iribarren, J.A.; López, P.; Barrio, J.; Von Wichmann, M.A.; Alzate, L.F.; Arrizabalaga, J.; Rodríguez, F.; Arenas, J.I. 1998: AIDS-associated cholangiopathy in a series of ten patients. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 90(6): 419-430

Moulignier, A.; Mikol, J.; Gonzalez-Canali, G.; Polivka, M.; Pialoux, G.; Welker, Y.; Alain, S.; Thiebaut, J.B.; Dupont, B. 1996: AIDS-associated cytomegalovirus infection mimicking central nervous system tumors: a diagnostic challenge. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 22(4): 626-631

Podell, M.; Oglesbee, M.; Mathes, L.; Krakowka, S.; Olmstead, R.; Lafrado, L. 1993: AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndromes 6(7): 758-771

Wagner, R.P.; Tian, H.; McPherson, M.J.; Latham, P.S.; Orenstein, J.M. 1996: AIDS-associated infections in salivary glands: autopsy survey of 60 cases. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 22(2): 369-371

Soriano-Rosas, J.; Avila-Casado, M.C.; Carrera-Gonzalez, E.; Chavez-Mercado, L.; Cruz-Ortiz, H.; Rojo, J. 1998: AIDS-associated nephropathy: 5-year retrospective morphologic analysis of 87 cases. Pathology Research and Practice 194(8): 567-570

Moulignier, A.; Mikol, J.; Pialoux, G.; Fénelon, G.; Gray, F.; Thiebaut, J.B. 1995: AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. American Journal of Medicine 99(1): 64-68

Tan, S.V.; Guiloff, R.J.; Scaravilli, F. 1995: AIDS-associated vacuolar myelopathy. a morphometric study. Brain: a Journal of Neurology 118: 1247-1261

d'Arminio Monforte, A.; Vago, L.; Lazzarin, A.; Boldorini, R.; Bini, T.; Guzzetti, S.; Antinori, S.; Moroni, M.; Costanzi, G. 1992: AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. Aids 6(10): 1159-1164

Kamps, B.S.; Brodt, H.R.; Staszewski, S.; Bergmann, L.; Helm, E.B. 1994: AIDS-free survival and overall survival in HIV infection: The new CDC classification system (1993) for HIV disease and AIDS. Clinical Investigator 72(4): 283-287

Gaidano, G.; Contarini, M.; Pastore, C.; Saglio, G.; Matera, L. 1996: AIDS-related Burkitt's-type lymphokine-activated killers induced by interleukin-2 and prolactin. Proceedings of the Society for Experimental Biology and Medicine 213(2): 196-205

Mathews, V.P.; Alo, P.L.; Glass, J.D.; Kumar, A.J.; McArthur, J.C. 1992: AIDS-related CNS cryptococcosis: radiologic-pathologic correlation. Ajnr. American Journal of Neuroradiology 13(5): 1477-1486

Gruden, J.F.; Huang, L.; Webb, W.R.; Gamsu, G.; Hopewell, P.C.; Sides, D.M. 1995: AIDS-related Kaposi sarcoma of the lung: radiographic findings and staging system with bronchoscopic correlation. Radiology 195(2): 545-552

Guo, W.X.; Antakly, T. 1995: AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. American Journal of Pathology 146(3): 727-734

Siskin, G.P.; Haller, J.O.; Miller, S.; Sundaram, R. 1995: AIDS-related lymphoma: radiologic features in pediatric patients. Radiology 196(1): 63-66

Meltzer, C.C.; Wells, S.W.; Becher, M.W.; Flanigan, K.M.; Oyler, G.A.; Lee, R.R. 1998: AIDS-related MR hyperintensity of the basal ganglia. Ajnr. American Journal of Neuroradiology 19(1): 83-89

Burman, W.J.; Stone, B.L.; Brown, B.A.; Wallace, R.J.; Böttger, E.C. 1998: AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. Diagnostic Microbiology and Infectious Disease 31(2): 369-371

Bandawe, C.R.; Foster, D. 1996: AIDS-related beliefs, attitudes and intentions among Malawian students in three secondary schools. Aids Care 8(2): 223-232

Thiele, J.; Zirbes, T.K.; Bertsch, H.P.; Titius, B.R.; Lorenzen, J.; Fischer, R. 1996: AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Analytical Cellular Pathology: the Journal of the European Society for Analytical Cellular Pathology 11(3): 141-157

Marelle, L.; Raphael, M.; Henin, D.; Vazeux, R.; Schuller, E.; Piette, J.C.; Poisson, M.; Gentilini, M.; Hauw, J.J. 1994: AIDS-related brain lymphomas: Clinical study and clinico-pathological correlations. Revue Neurologique (Paris) 150(2): 123-132

Parker, M.S.; Leveno, D.M.; Campbell, T.J.; Worrell, J.A.; Carozza, S.E. 1998: AIDS-related bronchogenic carcinoma: fact or fiction?. Chest 113(1): 154-161

Farman, J.; Brunetti, J.; Baer, J.W.; Freiman, H.; Comer, G.M.; Scholz, F.J.; Koehler, R.E.; Laffey, K.; Green, P.; Clemett, A.R. 1994: AIDS-related cholangiopancreatographic changes. Abdominal Imaging 19(5): 417-422

Benhamou, Y.; Caumes, E.; Gerosa, Y.; Cadranel, J.F.; Dohin, E.; Katlama, C.; Amouyal, P.; Canard, J.M.; Azar, N.; Hoang, C. 1993: AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients. Digestive Diseases and Sciences 38(6): 1113-1118

Bouche, H.; Housset, C.; Dumont, J.L.; Carnot, F.; Menu, Y.; Aveline, B.; Belghiti, J.; Boboc, B.; Erlinger, S.; Berthelot, P. 1993: AIDS-related cholangitis: diagnostic features and course in 15 patients. Journal of Hepatology 17(1): 34-39

Bird, G.L.; Kennedy, D.H.; Forrest, J.A. 1995: AIDS-related cholangitis: diagnostic features and course in four patients. Scottish Medical Journal 40(2): 53-54

Jougla, E.; Péquignot, F.; Carbon, C.; Pavillon, G.; Mireille, E.B.; Bourdais, J.P.; Bourdais, O.; Hatton, F. 1996: AIDS-related conditions: study of a representative sample of 1203 patients deceased in 1992 in France. International Journal of Epidemiology 25(1): 190-197

Taborda, A.; Negroni, R.; Arechavala, A.; Robles, A.M. 1993: AIDS-related cryptococcosis retrospective study of three antifungal therapies in 43 cases. Revista Iberoamericana de Micologia 10(1): 10-13

Sprinz, E.; Mallman, R.; Barcellos, S.; Silbert, S.; Schestatsky, G.; Bem David, D. 1998: AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin. Journal of Antimicrobial ChemoTherapy 41(Suppl): 85-91

Castro, R.; Orozco, E.; Eroza, E.; Manca, M.C.; Hernández, J.J.; Aggleton, P. 1998: AIDS-related illness trajectories in Mexico: findings from a qualitative study in two marginalized communities. Aids Care 10(5): 583-598

Elzubier, A.G.; el Nour, M.H.; Ansari, E.H. 1996: AIDS-related knowledge and misconceptions among high secondary school teachers and students in Kassala, Sudan. East African Medical Journal 73(5): 295-297

Adrien, A.; Boivin, J.F.; Hankins, C.; Leaune, V.; Tousignant, Y.; Tremblay, J. 1994: Aids-related knowledge and practices in migrant populations: the case of Montrealers of Haitian origin. Revue d'Epidemiologie et de Sante Publique 42(1): 50-57

Nyamathi, A.; Bennett, C.; Leake, B.; Lewis, C.; Flaskerud, J. 1993: AIDS-related knowledge, perceptions, and behaviors among impoverished minority women. American Journal of Public Health 83(1): 65-71

Bacchi, C.E.; Bacchi, M.M.; Rabenhorst, S.H.; Soares, F.A.; Fonseca, L.E.; Barbosa, H.S.; Weiss, L.M.; Gown, A.M. 1996: AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus. American Journal of Clinical Pathology 105(2): 230-237

Tulpule, A.; Matheny, S.C. 1998: AIDS-Related malignancies. Primary Care 25(2): 473-482

Radin, D.R.; Esplin, J.A.; Levine, A.M.; Ralls, P.W. 1993: AIDS-related non-Hodgkin's lymphoma: abdominal CT findings in 112 patients. Ajr. American Journal of Roentgenology 160(5): 1133-1139

Jones, W.F.; Sheikh, M.Y.; McClave, S.A. 1997: AIDS-related non-Hodgkin's lymphoma of the pancreas. American Journal of Gastroenterology 92(2): 335-338

Gaidano, G.; Pastore, C.; Gloghini, A.; Volpe, G.; Ghia, P.; Saglio, G.; Carbone, A. 1996: AIDS-related non-Hodgkin's lymphomas: molecular genetics, viral infection and cytokine deregulation. Acta Haematologica 95(3-4): 193-198

Kraus, R.P.; Nicholson, I.R. 1996: AIDS-related obsessive compulsive disorder: Deconditioning based on fluoxetine-induced inhibition of anxiety. Journal of Behavior Therapy and Experimental Psychiatry 27(1): 51-56

Sadun, A.A.; Pepose, J.S.; Madigan, M.C.; Laycock, K.A.; Tenhula, W.N.; Freeman, W.R. 1995: AIDS-related optic neuropathy: A histological, virological and ultrastructural study. Graefe's Archive for Clinical and Experimental Ophthalmology 233(7): 387-398

Sabaté, J.M.; Franquet, T.; Palmer, J.; Monill, J.M. 1997: AIDS-related primary esophageal lymphoma. Abdominal Imaging 22(1): 11-13

Mansour, G.; Charlotte, F.; Calvez, V.; Davi, F.; Merle-Béral, H. 1998: AIDS-related primary lymphoma of the pleural cavity. A case report. Acta Cytologica 42(2): 371-373

Ray, P.; Antoine, M.; Mary-Krause, M.; Lebrette, M.G.; Wislez, M.; Duvivier, C.; Meyohas, M.C.; Girard, P.M.; Mayaud, C.; Cadranel, J. 1998: AIDS-related primary pulmonary lymphoma. American Journal of Respiratory and Critical Care Medicine 158(4): 1221-1229

Metersky, M.L.; Colt, H.G.; Olson, L.K.; Shanks, T.G. 1995: AIDS-related spontaneous pneumothorax. Risk factors and treatment. Chest 108(4): 946-951

Irova, T.; Ninane, J. 1995: AIDS-resembling disease in a non-HIV-infected African born to an HIV-positive mother. Pediatric Hematology and Oncology 12(5): 495-498

Livingston, I.L. 1992: AIDS/HIV crisis in developing countries: the need for greater understanding and innovative health promotion approaches. Journal of the National Medical Association 84(9): 755-770

Conti, S.; Lepri, A.C.; Farchi, G.; Napoli, P.A.; Prati, S.; Rezza, G. 1996: AIDS: a major health problem among young Italian women. Aids 10(4): 407-411

Ugwaunyi, J.U. 1994: AIDS: A threat to African survival. Discovery and Innovation 6(1): 30-34

Odujinrin, O.M.; Adegoke, O.A. 1995: AIDS: Awareness and blood handling practices of health care workers in Lagos, Nigeria. European Journal of Epidemiology 11(4): 425-430

Feinberg, M.B.; McLean, A.R. 1997: AIDS: decline and fall of immune surveillance?. Current Biology: Cb 7(3): R136-R140

Arpini, R.; Chapo, R. 1993: AIDS: Importance in dermatology. Revista Argentina de Dermatologia 74(4): 164-170

Secchi, Juan-Carlos 1996: AIDS: Primum non nocere. Prensa Medica Argentina 83(1): 77-81

Casini, G.; Rickman, D.W.; Brecha, N.C. 1995: AIi amacrine cell population in the rabbit retina: identification by parvalbumin immunoreactivity. Journal of Comparative Neurology 356(1): 132-142

Hartveit, E.; Veruki, M.L. 1997: AII amacrine cells express functional NMDA receptors. Neuroreport 8(5): 1219-1223

Kozuru, M.; Hashimoto, M.; Takahira, H.; Uike, N.; Ohoshima, K.; Takeshita, M.; Kikuchi, M. 1996: AILD-like dysplasia transformed in AILD-type T cell lymphoma in an HTLV-1 carrier: usefulness of interferon-alpha. Acta Haematologica 96(2): 92-98

Leo, T. 1994: AIM Project A2002: CAMARC-II (computer aided movement analysis in a rehabilitation context-II). Computer Methods and Programs in Biomedicine 45(1-2): 11-13

Kuhn, M.H. 1994: AIM Project A2003: COmputer VIsion in RAdiology (COVIRA). Computer Methods and Programs in Biomedicine 45(1-2): 17-31

Terada, Y.; Tatsuka, M.; Suzuki, F.; Yasuda, Y.; Fujita, S.; Otsu, M. 1998: AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO Journal 17(3): 667-676

Ray, M.E.; Wistow, G.; Su, Y.A.; Meltzer, P.S.; Trent, J.M. 1997: AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proceedings of the National Academy of Sciences of the United States of America 94(7): 3229-3234

Gania, L.; Duquesnoy, B.; Thevenon, A. 1993: AIMS: A new approach to rheumatoid arthritis: Feasibility study. Annales de Readaptation et de Medecine Physique 36(1): 47-52

Reeves, P.G.; Nielsen, F.H.; Fahey, G.C. 1993: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Journal of Nutrition 123(11): 1939-1951

Holt, M.S.; Waters, J.; Comber, M.H.I.; Armitage, R.; Morris, G.; Newbery, C. 1995: AIS/CESIO Environmental surfactant monitoring programme. SDIA sewage treatment pilot study on linear alkylbenzene sulphonate (LAS). Water Research 29(9): 2063-2070

Feijtel, T.C.J.; Matthijs, E.; Rottiers, A.; Rijs, G.B.J.; Kiewiet, A.; De-Nijs, A. 1995: AIS/CESIO environmental surfactant monitoring programme. Part 1: LAS monitoring study in de Meern sewage treatment plant and receiving river Leidsche Rijn. Chemosphere 30(6): 1053-1066

Waters, J.; Feijtel, T.C. 1995: AIS/CESIO environmental surfactant monitoring programme: Outcome of five national pilot studies on linear alkylbenzene sulphonate (LAS). Chemosphere 30(10): 1939-1956

Middlemiss, P.J.; Glasky, A.J.; Rathbone, M.P.; Werstuik, E.; Hindley, S.; Gysbers, J. 1995: AIT-082, a unique purine derivative, enhances nerve growth factor mediated neurite outgrowth from PC12 cells. Neuroscience Letters 199(2): 131-134

Jassim, A.; Chen, Y.L. 1994: AJ-FS1 monoclonal antibody detects a novel group of non-glycosylated antigens within the human sperm tail fibrous sheath. Human Reproduction 9(8): 1459-1465

Jassim, A. 1994: AJ-FS9 monoclonal antibody detects masked antigens within the human sperm tail fibrous sheath. Human Reproduction 9(10): 1836-1844

Jassim, A.; Foxon, R.; Purkis, P.; Gray, A.; Al-Zuhdi, Y. 1993: AJ-p90: a novel protein of the perinuclear theca in human sperm subacrosome. Journal of Reproductive Immunology 23(2): 169-188

Karle, C.A.; Yao, X.; Kreye, V.A. 1998: A K+ single channel and whole-cell clamp study on the effects of levocromakalim in guinea pig portal vein cells. Naunyn-Schmiedeberg's Archives of Pharmacology 358(3): 374-381

Hegde, S.P.; Bright, J.J.; Kausalya, S.; Khar, A. 1995: AK-5 tumor-induced expression of interleukin-12: role of IL-12 in NK-mediated AK-5 regression. Cellular Immunology 162(2): 241-247

Tibbs, V.C.; Gray, P.C.; Catterall, W.A.; Murphy, B.J. 1998: AKAP15 anchors cAMP-dependent protein kinase to brain sodium channels. Journal of Biological Chemistry 273(40): 25783-25788

Kashishian, A.; Howard, M.; Loh, C.; Gallatin, W.M.; Hoekstra, M.F.; Lai, Y. 1998: AKAP79 inhibits calcineurin through a site distinct from the immunophilin-binding region. Journal of Biological Chemistry 273(42): 27412-27419

Nelson, D., B.; Salcido, R., C. 1997: AKC Nevada: Developing a platform for public health communications. American Journal of Preventive Medicine 13(2 Suppl): 23-25

Akeda, Y.; Shibata, K.; Ping, X.; Tanaka, T.; Taniguchi, M. 1995: AKD-2A, B, C and D, new antibiotics from Streptomyces sp. OCU-42815. Taxonomy, fermentation, isolation, structure elucidation and biological activity. Journal of Antibiotics 48(5): 363-368

Fischer-Lougheed, J.; O'shea, M.; Cornish, I.; Losberger, C.; Roulet, E.; Schulz-Aellen, M.-Francoise 1993: AKH biosynthesis: Transcriptional and translational control of two colocalized prohormones. Journal of Experimental Biology 177: 223-241

Rich, R.F.; Green, W.R. 1996: AKR.H-2b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation. Journal of Virology 70(1): 402-414

Liu, A.X.; Testa, J.R.; Hamilton, T.C.; Jove, R.; Nicosia, S.V.; Cheng, J.Q. 1998: AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Research 58(14): 2973-2977

Tague, R.G.; Lovejoy, C.O. 1998: AL 288-1--Lucy or Lucifer: gender confusion in the Pliocene. Journal of Human Evolution 35(1): 75-94

Miliani, A.; Bergesio, F. 1994: AL-amyloidosis in monoclonal gammopathies. Haematologica 79(4): 364-366

Berent, R.; Auer, J.; Punzengruber, C.; Oppitz, P.; Baldinger, C.; Kramar, R.; Pachinger, O. 1998: AL-amyloidosis: A hematologic disease with cardiac manifestation. 2 case reports. Zeitschrift fuer Kardiologie 87(6): 487-491

Yamauchi, T.; Matzno, S.; Imada, T.; Eda, M.; Inoue, Y.; Nakamura, N. 1996: AL0671, a new potassium channel opener, inhibits nonenzymatic glycation of protein and LDL oxidation. General Pharmacology 27(2): 257-262

Yon, C.; Suh, J.W.; Chang, J.H.; Lim, Y.; Lee, C.H.; Lee, Y.S.; Lee, Y.W. 1995: AL072, a novel anti-Legionella antibiotic produced by Streptomyces sp. Journal of Antibiotics 48(8): 773-779

Mosello, R.; Wathne, B.M.; Lien, L.; Birks, H.J.B. 1995: AL:PE projects: Water chemistry and critical loads. Water Air and Soil Pollution 85(2): 493-498

Buys, A.J.; Van-Vuuren, J.A.J.; Coetzee, J.G.K.; Claassens, A.S.; Barnard, R.O. 1996: ALASA: Agricultural laboratory association of southern Africa - ensuring reliable analyses. Communications in Soil Science and Plant Analysis 27(5-8): 1571-1578

Burton, R., E.; Busby, R., S.; Oas, T., G. 1998: ALASKA: A Mathematica package for two-state kinetic analysis of protein folding reactions. Journal of Biomolecular NMR 11(3): 355-360

Freeman, W.; Fox, J. 1995: ALAWAT: A spatially allocated watershed model for approximating stream, sediment, and pollutant flows in Hawaii, USA. Environmental Management 19(4): 567-577

Rossiter, D.; Howard, D.M. 1996: ALBERT: a real-time visual feedback computer tool for professional vocal development. Journal of Voice: Official Journal of the Voice Foundation 10(4): 321-336

Shivalkar, B.; Borgers, M.; Daenen, W.; Gewillig, M.; Flameng, W. 1994: ALCAPA syndrome: An example of chronic myocardial hypoperfusion?. Journal of the American College of Cardiology 23(3): 772-778

Suzuki, K.; Muramatsu, T.; Yamada, K.; Kono, H. 1992: ALDH phenotype in eating disorders with and without alcoholism. Arukoru Kenkyu to Yakubutsu Izon 27(6): 629-633

Kawamoto, T.; Matsuno, K.; Kodama, Y.; Murata, K.; Matsuda, S. 1994: ALDH2 polymorphism and biological monitoring of toluene. Archives of Environmental Health 49(5): 332-336

Kemp, S.; Mooyer, P.A.; Bolhuis, P.A.; van Geel, B.M.; Mandel, J.L.; Barth, P.G.; Aubourg, P.; Wanders, R.J. 1996: ALDP expression in fibroblasts of patients with X-linked adrenoleukodystrophy. Journal of Inherited Metabolic Disease 19(5): 667-674

Possingham, H.P.; Davies, I. 1995: ALEX: A model for the viability analysis of spatially structured populations. Biological Conservation 73(2): 143-150

Rosoiu, N.; Lascarache, G.H. 1994: ALFLUTOP: A natural extraction drug used for the treatment of degenerative rheumatic diseases. Revue Roumaine de Biochimie 31(1): 57-63

Resenchuk, S.M.; Blinov, V.M. 1995: ALIGNMENT SERVICE: creation and processing of alignments of sequences of unlimited length. Computer Applications in the Biosciences: Cabios 11(1): 7-11

Falini, B.; Bigerna, B.; Fizzotti, M.; Pulford, K.; Pileri, S.A.; Delsol, G.; Carbone, A.; Paulli, M.; Magrini, U.; Menestrina, F.; Giardini, R.; Pilotti, S.; Mezzelani, A.; Ugolini, B.; Billi, M.; Pucciarini, A.; Pacini, R.; Pelicci, P.G.; Flenghi, L. 1998: ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. American Journal of Pathology 153(3): 875-886

Herbst, H.; Anagnostopoulos, J.; Heinze, B.; Dürkop, H.; Hummel, M.; Stein, H. 1995: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86(5): 1694-1700

Benharroch, D.; Meguerian-Bedoyan, Z.; Lamant, L.; Amin, C.; Brugières, L.; Terrier-Lacombe, M.J.; Haralambieva, E.; Pulford, K.; Pileri, S.; Morris, S.W.; Mason, D.Y.; Delsol, G. 1998: ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91(6): 2076-2084

Giona, F.; Testi, A.M.; Rondelli, R.; Amadori, S.; Arcese, W.; Meloni, G.; Moleti, M.L.; Ceci, A.; Pillon, M.; Madon, E.; Comis, M.; Pession, A.; Mandelli, F. 1997: ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse. British Journal of Haematology 99(3): 671-677

Cimino, G.; Lo Coco, F.; Biondi, A.; Elia, L.; Luciano, A.; Croce, C.M.; Masera, G.; Mandelli, F.; Canaani, E. 1993: ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 82(2): 544-546

Felix, C.A.; Hosler, M.R.; Winick, N.J.; Masterson, M.; Wilson, A.E.; Lange, B.J. 1995: ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85(11): 3250-3256

Cimino, G.; Rapanotti, M.C.; Elia, L.; Biondi, A.; Fizzotti, M.; Testi, A.M.; Tosti, S.; Croce, C.M.; Canaani, E.; Mandelli, F. 1995: ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age. Cancer Research 55(8): 1625-1628

Leshkowitz, D.; Rozenblatt, O.; Nakamura, T.; Yano, T.; Dautry, F.; Croce, C.M.; Canaani, E. 1996: ALL-1 interacts with unr, a protein containing multiple cold shock domains. Oncogene 13(9): 2027-2031

Schichman, S.A.; Caligiuri, M.A.; Gu, Y.; Strout, M.P.; Canaani, E.; Bloomfield, C.D.; Croce, C.M. 1994: ALL-1 partial duplication in acute leukemia. Proceedings of the National Academy of Sciences of the United States of America 91(13): 6236-6239

Schichman, S.A.; Caligiuri, M.A.; Strout, M.P.; Carter, S.L.; Gu, Y.; Canaani, E.; Bloomfield, C.D.; Croce, C.M. 1994: ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Research 54(16): 4277-4280

Venditti, A.; Stasi, R.; Masi, M.; Del Poeta, G.; Cox, C.; Franchi, A.; Piccioni, D.; Bruno, A.; Coppetelli, U.; Tribalto, M. 1993: All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemias. Annals of Hematology 66(2): 59-60

Baldus, M.; Walter, H.; Moeller, M.; Schuerfeld, C.; Brass, H. 1994: ALL-Trans retinoic acid (ATRA) in the treatment of myelodysplastic syndromes: Results in 5 cases. Onkologie 17(5): 515-520

Cimino, G.; Rapanotti, M.C.; Sprovieri, T.; Elia, L. 1998: ALL1 gene alterations in acute leukemia: biological and clinical aspects. Haematologica 83(4): 350-357

Beavis, A.J.; Pennline, K.J. 1996: Allo-7: a new fluorescent tandem dye for use in flow cytometry. Cytometry 24(4): 390-395

Robert, V.; Buyck, B. 1996: ALLRUS: A system for standard description, identification and classification of Russulaceae. Mycotaxon 60: 471-480

Porat, R.; Lu, P.; O'neill, S.D. 1998: ALPHArabidopsis SKP1, a homologue of a cell cycle regulator gene, is predominantly expressed in meristematic cells. Planta (Berlin) 204(3): 345-351

Anderson, F.A.; Miller, R.G. 1996: ALS care: a resource for measuring and improving ALS outcomes. Neurology 47(4 Suppl 2): S113

Bruijn, L.I.; Becher, M.W.; Lee, M.K.; Anderson, K.L.; Jenkins, N.A.; Copeland, N.G.; Sisodia, S.S.; Rothstein, J.D.; Borchelt, D.R.; Price, D.L.; Cleveland, D.W. 1997: ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18(2): 327-338

Malvezzi, F.; Castellani, C.; Ferrandino, A.; Ruscica, C. 1993: ALTP: Five-years efficacy and possible correlation with some clinical parameters. Annali di Ottalmologia e Clinica Oculistica 119(2): 209-215

Bruhn, L.; Munnerlyn, A.; Grosschedl, R. 1997: ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes and Development 11(5): 640-653

Fallon, M.B.; Mennone, A.; Anderson, J.M. 1993: Altered expression and localization of the tight junction protein ZO-1 after common bile duct ligation. American Journal of Physiology 264(6 Part 1): C1439-C1447

West, J.K.; Hench, L.L. 1994: AM-1 molecular orbital calculations of silica-alanine-nitrogen interaction. Journal of Biomedical Materials Research 28(5): 625-633

Zeng, L.; Takeya, M.; Takahashi, K. 1996: AM-3K, a novel monoclonal antibody specific for tissue macrophages and its application to pathological investigation. Journal of Pathology 178(2): 207-214

Zhao, M.; Hollingworth, S.; Baylor, S.M. 1997: AM-loading of fluorescent Ca2+ indicators into intact single fibers of frog muscle. Biophysical Journal 72(6): 2736-2747

Ciarkowski, J.; Oldziej, S. 1993: AM1 and PM3 study of a low molecular weight structural mimic of hydrogen exchange within the catalytic center of aspartic proteases. European Biophysics Journal 22(3): 207-212

Cramer, C.J.; Truhlar, D.G. 1992: AM1-SM2 and PM3-SM3 parameterized SCF solvation models for free energies in aqueous solution. Journal of Computer-Aided Molecular Design 6(6): 629-666

Güenechea, G.; Albella, B.; Bueren, J.A.; Maganto, G.; Tuduri, P.; Guerrero, A.; Pivel, J.P.; Real, A. 1997: AM218, a new polyanionic polysaccharide, induces radioprotection in mice when administered shortly before irradiation. International Journal of Radiation Biology 71(1): 101-108

Güenechea, G.; Bueren, J.A.; Maganto, G.; Tuduri, P.; Guerrero, A.; Pivel, J.P.; Real, A. 1995: AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures. Stem Cells 13(2): 175-185

Gianní, M.; Li Calzi, M.; Terao, M.; Guiso, G.; Caccia, S.; Barbui, T.; Rambaldi, A.; Garattini, E. 1996: AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells. Blood 87(4): 1520-1531

Hosohata, K.; Quock, R.M.; Hosohata, Y.; Burkey, T.H.; Makriyannis, A.; Consroe, P.; Roeske, W.R.; Yamamura, H.I. 1997: AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain. Life Sciences 61(9): Pl115-Pl118

Pertwee, R.; Griffin, G.; Fernando, S.; Li, X.; Hill, A.; Makriyannis, A. 1995: AM630, a competitive cannabinoid receptor antagonist. Life Sciences 56(23-24): 1949-1955

Geleijns, J.; Broerse, J.J.; Julius, H.W.; Vrooman, H.A.; Zoetelief, J.; Zweers, D.; Kool, L.J. 1992: AMBER and conventional chest radiography: comparison of radiation dose and image quality. Radiology 185(3): 719-723

Abuknesha, R.A.; Al-Mazeedi, H.M.; Price, R.G. 1992: AMC-anti-FITC conjugates: novel reagents for amplified immunochemical techniques. Immunofluorescent staining of human fibroblasts. Histochemical Journal 24(9): 655-662

Donzella, G.A.; Schols, D.; Lin, S.W.; Esté, J.A.; Nagashima, K.A.; Maddon, P.J.; Allaway, G.P.; Sakmar, T.P.; Henson, G.; De Clercq, E.; Moore, J.P. 1998: AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nature Medicine 4(1): 72-77

Leroux, B.G.; Krewski, D. 1993: AMESFIT: A microcomputer program for fitting linear-exponential dose-response models in the Ames Salmonella assay. Environmental and Molecular Mutagenesis 22(2): 78-84

Nabi, I.R.; Guay, G.; Simard, D. 1997: AMF-R tubules concentrate in a pericentriolar microtubule domain after MSV transformation of epithelial MDCK cells. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 45(10): 1351-1363

Garkavi, L.K.; Kvakina, E.B.; Sheiko, E.A. 1996: AMF-induced enhancement of thio-tepa antitumor effect in the rats with transplantable ovarian tumor. Eksperimental'naya Onkologiya 18(1): 87-89

Vassallo, P.; Matei, C.; Heston, W.D.; McLachlan, S.J.; Koutcher, J.A.; Castellino, R.A. 1994: AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 193(2): 501-506

Lynch, D.R.; Kawchuk, L.M.; Schaupmeyer, C.A.; Holley, J.; Waterer, D.; Rex, B.L.; Pritchard, M.K.; Panford, J. 1995: AMISK: A clonal variant of Ranger Russet. American Potato Journal 72(3): 185-189

Weidmann, E.; Brieger, J.; Bergmann, L.; Hoelzer, D.; Mitrou, P.S. 1995: AML blasts variably express interleukin 2 receptor alpha, beta or gamma chains without measurable effects on proliferation, cytokine message expression or surface expression of adhesion molecules upon stimulation with interleukin 2. Leukemia Research 19(7): 469-476

Zhang, T.; Hillion, J.; Tong, J.H.; Cao, Q.; Chen, S.J.; Berger, R.; Chen, Z. 1994: AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 8(5): 729-734

Sacchi, N.; Nisson, P.E.; Watkins, P.C.; Faustinella, F.; Wijsman, J.; Hagemeijer, A. 1994: AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes Chromosomes and Cancer 11(4): 226-236

Zhu, X.; Yeadon, J.E.; Burden, S.J. 1994: AML1 is expressed in skeletal muscle and is regulated by innervation. Molecular and Cellular Biology 14(12): 8051-8057

Levanon, D.; Negreanu, V.; Bernstein, Y.; Bar-Am, I.; Avivi, L.; Groner, Y. 1994: AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23(2): 425-432

Okuda, T.; Van Deursen, J.; Hiebert, S.W.; Grosveld, G.; Downing, J.R. 1996: AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84(2): 321-330

Wigle, D.A.; Thompson, K.E.; Yablonsky, S.; Zaidi, S.H.; Coulber, C.; Jones, P.L.; Rabinovitch, M. 1998: AML1-like transcription factor induces serine elastase activity in ovine pulmonary artery smooth muscle cells. Circulation Research 83(3): 252-263

Kusec, R.; Laczika, K.; Knöbl, P.; Friedl, J.; Greinix, H.; Kahls, P.; Linkesch, W.; Schwarzinger, I.; Mitterbauer, G.; Purtscher, B. 1994: AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 8(5): 735-739

Niitsu, N.; Yamamoto-Yamaguchi, Y.; Miyoshi, H.; Shimizu, K.; Ohki, M.; Umeda, M.; Honma, Y. 1997: AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 8(3): 319-326

Reuss-Borst, M.A.; Bühring, H.J.; Schmidt, H.; Müller, C.A. 1994: AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 8(2): 258-263

Parker, B.A.; Santarelli, M.; Green, M.R.; Anderson, J.R.; Cooper, M.R.; Case, D.; Barcos, M.; Peterson, B.A.; Gottlieb, A.J. 1993: AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(2): 248-254

Zhao, F.K.; Xu, S.Q.; Xu, G.J. 1998: AMP activation of snake muscle fructose 1,6-bisphosphatase at alkaline pH. Biochemical and Biophysical Research Communications 244(3): 928-932

Rundell, K.W.; Tullson, P.C.; Terjung, R.L. 1993: AMP deaminase binding in rat skeletal muscle after high-intensity running. Journal of Applied Physiology 74(4): 2004-2006

Sharoyan, S.; Mardanian, S.; Haroutunian, A. 1994: AMP deaminase from anterior lobe of bovine pituitary: purification and properties. Acta Biochimica Polonica 41(1): 97-101

Norman, B.; Hellsten-Westing, Y.; Sjödin, B.; Jansson, E. 1994: AMP deaminase in skeletal muscle of healthy males quantitatively determined by new assay. Acta Physiologica Scandinavica 150(4): 397-403

Chen, W.; Guéron, M. 1996: AMP degradation in the perfused rat heart during 2-deoxy-D-glucose perfusion and anoxia. Part II: the determination of the degradation pathways using an adenosine deaminase inhibitor. Journal of Molecular and Cellular Cardiology 28(10): 2175-2182

Lewis, M.D.; Webster, J.; Ham, J.; Davies, J.S.; Scanlon, M.F. 1996: AMP is a component of the low molecular weight mitogenic activity present in human pituitary tumours. Journal of Clinical Endocrinology and Metabolism 81(3): 1296-1298

Chilson, O.P.; Kelly-Chilson, A.E.; Siegel, N.R. 1997: AMP-deaminases from chicken and rabbit muscle: partial primary sequences of homologous 17-kDa CNBr fragments: autorecognition by rabbit anti-[chicken AMPD. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 116(3): 371-377

Foretz, M.; Carling, D.; Guichard, C.; Ferré, P.; Foufelle, F. 1998: AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. Journal of Biological Chemistry 273(24): 14767-14771

Stapleton, D.; Woollatt, E.; Mitchelhill, K.I.; Nicholl, J.K.; Fernandez, C.S.; Michell, B.J.; Witters, L.A.; Power, D.A.; Sutherland, G.R.; Kemp, B.E. 1997: AMP-activated protein kinase isoenzyme family: Subunit structure and chromosomal location. FEBS Letters 409(3): 452-456

Salt, I.; Celler, J.W.; Hawley, S.A.; Prescott, A.; Woods, A.; Carling, D.; Hardie, D.G. 1998: AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochemical Journal 334: 177-187

Nagel-Starczynowska, G.; Kaletha, K. 1993: AMP-deaminase from human uterine smooth muscle: The effect of DTNB treatment on kinetic and regulatory properties of the enzyme. Biochimica et Biophysica Acta 1164(3): 261-267

Lushchak, V., I.; Smirnova, Y., D.; Storey, K., B. 1998: AMP-deaminase from sea scorpion white muscle: Properties and redistribution under hypoxia. Comparative Biochemistry and Physiology B 119(3): 611-618

Sawutz, D.G.; Krafte, D.S.; Oleynek, J.J.; Ault, B. 1995: AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors in human brain tissues. Journal of Receptor and Signal Transduction Research 15(6): 829-846

Kremer, B.; Tallaksen-Greene, S.J.; Albin, R.L. 1993: AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Neurology 43(8): 1593-1595

Paquet, M.; Tremblay, M.; Soghomonian, J.J.; Smith, Y. 1997: AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(4): 1377-1396

Matsumoto, M.; Zornow, M.H.; Scheller, M.S.; Strnat, M.A. 1992: AMPA and NMDA receptor antagonists do not decrease hippocampal glutamate concentrations during transient global ischemia. Anesthesiology 77(4): 764-771

Svendsen, F.; Tjølsen, A.; Hole, K. 1998: AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation. Neuroreport 9(6): 1185-1190

Gleason, E.L.; Spitzer, N.C. 1998: AMPA and NMDA receptors expressed by differentiating Xenopus spinal neurons. Journal of Neurophysiology 79(6): 2986-2998

LeBlanc, M.H.; Li, X.Q.; Huang, M.; Patel, D.M.; Smith, E.E. 1995: AMPA antagonist LY293558 does not affect the severity of hypoxic-ischemic injury in newborn pigs. Stroke 26(10): 1908

Stephens, D.N.; Cole, B.J. 1996: AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology 126(3): 249-259

Redmond, J.M.; Zehr, K.J.; Blue, M.E.; Lange, M.S.; Gillinov, A.M.; Troncoso, J.C.; Cameron, D.E.; Johnston, M.V.; Baumgartner, W.A. 1995: AMPA glutamate receptor antagonism reduces neurologic injury after hypothermic circulatory arrest. Annals of Thoracic Surgery 59(3): 579-584

Martin, L.J.; Blackstone, C.D.; Levey, A.I.; Huganir, R.L.; Price, D.L. 1993: AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53(2): 327-358

Eastwood, S.L.; Burnet, P.W.; Beckwith, J.; Kerwin, R.W.; Harrison, P.J. 1994: AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus. Neuroreport 5(11): 1325-1328

Cebers, G.; Zhivotovsky, B.; Ankarcrona, M.; Liljequist, S. 1997: AMPA neurotoxicity in cultured cerebellar granule neurons: Mode of cell death. Brain Research Bulletin 43(4): 393-403

Ge, Q.; Feldman, J.L. 1998: AMPA receptor activation and phosphatase inhibition affect neonatal rat respiratory rhythm generation. Journal of Physiology 509: 255-266

David, J.C.; Yamada, K.A.; Bagwe, M.R.; Goldberg, M.P. 1996: AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(1): 200-209

Yamada, K.A. 1998: AMPA receptor activation potentiated by the AMPA modulator 1-BCP is toxic to cultured rat hippocampal neurons. Neuroscience Letters 249(2-3): 119-122

Morari, M.; Calo, G.; Ferraro, L.; Fabrizi, A.; Acciarri, N.; Piazza, G.; Bianchi, C.; Beani, L. 1995: AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices. Neurochemistry International 26(1): 77-83

Matzen, L.; Engesgaard, A.; Ebert, B.; Didriksen, M.; Frølund, B.; Krogsgaard-Larsen, P.; Jaroszewski, J.W. 1997: AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid. Journal of Medicinal Chemistry 40(4): 520-527

Patel, T.R.; Mcculloch, J. 1995: AMPA receptor antagonism attenuates MK-801-induced hypermetabolism in the posterior cingulate cortex. Brain Research 686(2): 254-258

Yao, H.; Ibayashi, S.; Nakane, H.; Cai, H.; Uchimura, H.; Fujishima, M. 1997: AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats. Brain Research 753(1): 80-85

Browne, S.E.; Mcculloch, J. 1994: AMPA receptor antagonists and local cerebral glucose utilization in the rat. Brain Research 641(1): 10-20

Healy, D.J.; Haroutunian, V.; Powchik, P.; Davidson, M.; Davis, K.L.; Watson, S.J.; Meador-Woodruff, J.H. 1998: AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 19(4): 278-286

McFarlane, C.; Warner, D.S.; Todd, M.M.; Nordholm, L. 1992: AMPA receptor competitive antagonism reduces halothane MAC in rats. Anesthesiology 77(6): 1165-1170

Arai, A.; Lynch, G. 1998: AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices. Brain Research 799(2): 235-242

Brorson, J.R.; Manzolillo, P.A.; Gibbons, S.J.; Miller, R.J. 1995: AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(6): 4515-4524

Rogan, M.T.; Stäubli, U.V.; LeDoux, J.E. 1997: AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(15): 5928-5935

Partin, K.M.; Fleck, M.W.; Mayer, M.L. 1996: AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(21): 6634-6647

Jensen, J.B.; Schousboe, A.; Pickering, D.S. 1998: AMPA receptor mediated excitotoxicity in neocortical neurons is developmentally regulated and dependent upon receptor desensitization. Neurochemistry International 32(5-6): 505-513

Gagné, J.; Gélinas, S.; Martinoli, M.G.; Foster, T.C.; Ohayon, M.; Thompson, R.F.; Baudry, M.; Massicotte, G. 1998: AMPA receptor properties in adult rat hippocampus following environmental enrichment. Brain Research 799(1): 16-25

Martin, L.J.; Furuta, A.; Blackstone, C.D. 1998: AMPA receptor protein in developing rat brain: Glutamate receptor-1 expression and localization change at regional, cellular, and subcellular levels with maturation. Neuroscience 83(3): 917-928

Seifert, G.; Rehn, L.; Weber, M.; Steinhäuser, C. 1997: AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. Brain Research. Molecular Brain Research 47(1-2): 286-294

Popratiloff, A.; Weinberg, R.J.; Rustioni, A. 1996: AMPA receptor subunits underlying terminals of fine-caliber primary afferent fibers. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(10): 3363-3372

Itoh, T.; Itoh, A.; Horiuchi, K.; Pleasure, D. 1998: AMPA receptor-mediated excitotoxicity in human NT2-N neurons results from loss of intracellular Ca2+ homeostasis following marked elevation of intracellular Na+. Journal of Neurochemistry 71(1): 112-124

Lampinen, M.; Pentikäinen, O.; Johnson, M.S.; Keinänen, K. 1998: AMPA receptors and bacterial periplasmic amino acid-binding proteins share the ionic mechanism of ligand recognition. EMBO Journal 17(16): 4704-4711

Cumberbatch, M.J.; Chizh, B.A.; Headley, P.M. 1994: AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission. Neuroreport 5(8): 877-880

Hack, N.J.; Sluiter, A.A.; Balázs, R. 1995: AMPA receptors in cerebellar granule cells during development in culture. Brain Research. Developmental Brain Research 87(1): 55-61

Rabejac, D.; Devau, G.; Raymond, J. 1997: AMPA receptors in cultured vestibular ganglion neurons: Detection and activation. European Journal of Neuroscience 9(2): 221-228

Leranth, C.; Szeidemann, Z.; Hsu, M.; Buzsáki, G. 1996: AMPA receptors in the rat and primate hippocampus: A possible absence of GluR2/3 subunits in most interneurons. Neuroscience 70(3): 631-652

Sakai, K.; Akiyama, K.; Kashihara, K.; Tsuchida, K.; Ujike, H.; Kuroda, S.; Shohmori, T. 1997: AMPA receptors modulate dopamine release in the striatum, as measured by brain microdialysis. Neurochemistry International 30(3): 329-336

Maione, S.; Rossi, F.; Biggs, C.S.; Fowler, L.J.; Whitton, P.S. 1997: AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo. Neurochemistry International 30(3): 299-304

Holtzclaw, L.A.; Gallo, V.; Russell, J.T. 1995: AMPA receptors shape Ca2+ responses in cortical oligodendrocyte progenitors and CG-4 cells. Journal of Neuroscience Research 42(1): 124-130

Otis, T.S.; Raman, I.M.; Trussell, L.O. 1995: AMPA receptors with high Ca2+ permeability mediate synaptic transmission in the avian auditory pathway. Journal of Physiology 482: 309-315

Sato, K.; Kiyama, H.; Park, H.T.; Tohyama, M. 1993: AMPA, KA and NMDA receptors are expressed in the rat DRG neurones. Neuroreport 4(11): 1263-1265

Sheardown, M.J.; Suzdak, P.D.; Nordholm, L. 1993: AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. European Journal of Pharmacology 236(3): 347-353

Ikonomovic, M.D.; Sheffield, R.; Armstrong, D.M. 1995: AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease. Hippocampus 5(5): 469-486

Muir, J.L.; Everitt, B.J.; Robbins, T.W. 1994: AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(4): 2313-2326

Page, K.J.; Sirinathsinghji, D.J.; Everitt, B.J. 1995: AMPA-induced lesions of the basal forebrain differentially affect cholinergic and non-cholinergic neurons: Lesion assessment using quantitative in situ hybridization histochemistry. European Journal of Neuroscience 7(5): 1012-1021

Lukasiewicz, P.D.; Wilson, J.A.; Lawrence, J.E. 1997: AMPA-preferring receptors mediate excitatory synaptic inputs to retinal ganglion cells. Journal of Neurophysiology 77(1): 57-64

Ikonomovic, M.D.; Sheffield, R.; Armstrong, D.M. 1995: AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation. Journal of Comparative Neurology 359(2): 239-252

Armstrong, D.M.; Ikonomovic, M.D.; Sheffield, R.; Wenthold, R.J. 1994: AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Research 639(2): 207-216

Armstrong, D.M.; Ikonomovic, M.D. 1996: AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer disease. Evidence for hippocampal plasticity. Molecular and Chemical Neuropathology 28(1-3): 59-64

Hamlin, L.; Mackerlova, L.; Blomqvist, A.; Ericson, A.C. 1996: AMPA-selective glutamate receptor subunits and their relation to glutamate- and GABA-like immunoreactive terminals in the nucleus submedius of the rat. Neuroscience Letters 217(2-3): 149-152

Condorelli, D.F.; Dell'Albani, P.; Corsaro, M.; Barresi, V.; Giuffrida Stella, A.M. 1993: AMPA-selective glutamate receptor subunits in astroglial cultures. Journal of Neuroscience Research 36(3): 344-356

García-Barcina, J.M.; Matute, C. 1998: AMPA-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Brain Research. Molecular Brain Research 53(1-2): 270-276

Nicoletti, V.G.; Condorelli, D.F.; Dell'Albani, P.; Ragusa, N.; Giuffrida Stella, A.M. 1995: AMPA-selective glutamate receptor subunits in the rat hippocampus during aging. Journal of Neuroscience Research 40(2): 220-224

López, T.; López-Colomé, A.M.; Ortega, A. 1994: AMPA/KA receptor expression in radial glia. Neuroreport 5(4): 504-506

Sánchez, G.; Ortega, A. 1994: AMPA/KA receptor induced AP-1 DNA binding activity in cultured Bergmann glia cells. Neuroreport 5(16): 2109-2112

Kaddis, F.G.; Wallace, L.J.; Uretsky, N.J. 1993: AMPA/Kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists. Pharmacology Biochemistry and Behavior 46(3): 703-708

Miyawaki, T.; Minson, J.; Arnolda, L.; Llewellyn-Smith, I.; Chalmers, J.; Pilowsky, P. 1996: AMPA/Kainate receptors mediate sympathetic chemoreceptor reflex in the rostral ventrolateral medulla. Brain Research 726(1-2): 64-68

Freund, W.D.; Reddig, S. 1994: AMPA/Zn(2+)-induced neurotoxicity in rat primary cortical cultures: involvement of L-type calcium channels. Brain Research 654(2): 257-264

Houzen, H.; Kanno, M.; Kikuchi, S. 1998: AMPA/kainate receptor activation inhibits neuronal delayed rectifier K+ current via Na+ entry in rat cortical neurons. Biochemical and Biophysical Research Communications 243(2): 617-621

Pellegrini-Giampietro, D.E.; Bennett, M.V.; Zukin, R.S. 1994: AMPA/kainate receptor gene expression in normal and Alzheimer's disease hippocampus. Neuroscience 61(1): 41-49

Weiss, J.H.; Turetsky, D.; Wilke, G.; Choi, D.W. 1994: AMPA/kainate receptor-mediated damage to NADPH-diaphorase-containing neurons is Ca2+ dependent. Neuroscience Letters 167(1-2): 93-96

Bardoul, M.; Drian, M.J.; König, N. 1997: AMPA/kainate receptors modulate the survival in vitro of embryonic brainstem cells. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 15(6): 695-701

Woller, J.; Furedi, S.; Padar, Z. 1995: AMPFLP analysis of the VNTR loci D1S80 and ApoB in Hungary. International Journal of Legal Medicine 107(5): 273-274

Hernandez, A.; Bergmann, J.S.; Woods, G.L. 1997: AMPLICOR MTB polymerase chain reaction test for identification of Mycobacterium tuberculosis in positive Difco ESP II broth cultures. Diagnostic Microbiology and Infectious Disease 27(1-2): 17-20

Rammsayer, T.H.; Vogel, W.H. 1995: AMPT partially reverses euphoric but not psychomotor effects of alcohol in humans. Psychobiology 23(3): 248-255

Montague, D.K.; Angermeier, K.W.; Lakin, M.M.; Ingleright, B.J. 1996: AMS 3-piece inflatable penile prosthesis implantation in men with Peyronie's disease: Comparison of CX and Ultrex cylinders. Journal of Urology 156(5): 1633-1635

Wohlfarth, B.; Bjorck, S.; Possnert, G.; Lemdahl, G.; Brunnberg, L.; Ising, J.; Olsson, S.; Svensson, N.O.f 1993: AMS dating Swedish varved clays of the last glacial/interglacial transition and the potential/difficulties of calibrating Late Weichselian absolute chronologies. Boreas (oslo). 22(2): 113-128

D'errico, F.; Williams, C.T.; Stringer, C.B. 1998: AMS dating and microscopic analysis of the Sherborne bone. Journal of Archaeological Science 25(8): 777-787,.

Lichter, J. 1997: AMS radiocarbon dating of Lake Michigan beach-ridge and dune development. Quaternary Research (orlando). 48(1): 137-140

Oldfield, F.; Crooks, P., R.J.; Harkness, D., D.; Petterson, G. 1997: AMS radiocarbon dating of organic fractions from varved lake sediments: An empirical test of reliability. Journal of Paleolimnology 18(1): 87-91

Reyniers, E.; De Boulle, K.; Marchuk, D.A.; Andersen, L.B.; Collins, F.S.; Willems, P.J. 1993: AN EcoRI RFLP in the 5' region of the human NF1 gene. Human Genetics 92(6): 631

Marsili, M.; Saller, H. 1993: ANALOGS: A computer program for the design of multivariate sets of analog compounds. Journal of Chemical Information and Computer Sciences 33(2): 266-269

Bakker Schut, T.C.; Doornbos, R.M.; de Grooth, B.G. 1994: ANALYSIS: Software for graphical analysis of multidimensional flow cytometric list mode data. Computers and Biomedical Research An International Journal 27(2): 83-96

Sadasivan, P.K.; Dutt, D.N. 1996: ANC Schemes for the enhancement of EEG signals in the presence of EOG artifacts. Computers and Biomedical Research An International Journal 29(1): 27-40

Jayne, D.R.; Gaskin, G.; Pusey, C.D.; Lockwood, C.M. 1995: ANCA and predicting relapse in systemic vasculitis. Qjm: Monthly Journal of the Association of Physicians 88(2): 127-133

Nakabayashi, I.; Yoshizawa, N.; Kubota, T.; Akashi, Y.; Nishiyama, J.; Suzuki, Y.; Oshima, S.; Oda, T.; Niwa, H.; Yoshida, M. 1993: ANCA associated vasculitis allergica cutis (VAC) and mild proliferative necrotizing glomerulonephritis. Clinical Nephrology 40(5): 265-269

Gomes, J.A.; Neto, A.L.; Scheinberg, M.A. 1993: ANCA associated with scleritis and sclerosing keratitis. Clinical Rheumatology 12(3): 429-430

Weidemann, S.; Andrassy, K.; Ritz, E. 1993: ANCA in haemodialysis patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 8(9): 839-845

Falk, R.J.; Jennette, J.C. 1997: ANCA small-vessel vasculitis. Journal of the American Society of Nephrology: Jasn 8(2): 314-322

Gross, W.L.; Reinhold-Keller, E. 1995: ANCA-associated vasculitides (Wegener's Granulomatosis, Churg-Strauss Syndrome, microscopic polyangiitis): 1. Pathogenetic and clinical aspects. Zeitschrift fuer Rheumatologie 54(5): 279-290

De-Groot, K.; Schnabel, A.; Gross, W.L. 1995: ANCA-associated vasculitides (Wegener's Granulomatosis, Churg-Strauss Syndrome, microscopic polyangiitis): 2. Diagnostical procedure. Zeitschrift fuer Rheumatologie 54(5): 291-302

Reinhold-Keller, E.; Tatsis, E.; Gross, W.L. 1995: ANCA-associated vasculitides (Wegener's Granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis): 3. Therapeutical procedure. Zeitschrift fuer Rheumatologie 54(5): 303-309

Kawachi, Y.; Nukaga, H.; Hoshino, M.; Iwata, M.; Otsuka, F. 1995: ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clinical and Experimental Dermatology 20(4): 345-347

Parry, R.; Sherwin, S.; Fletcher, V.; Medcalf, P. 1996: ANCA-associated vasculitis: diagnosis and treatment in the elderly. Postgraduate Medical Journal 72(849): 423-426

Rychlík, I.; Tesar, V.; Stejskalová, A.; Stejskal, J.; Honsová, E.; Bartůnková, J. 1997: ANCA-positive Churg-Strauss syndrome with renal failure. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(4): 837-838

Messiaen, T.; Lefebvre, C.; Zech, F.; Cosyns, J.P.; Jadoul, M. 1997: ANCA-positive rapidly progressive glomerulonephritis: there may be more to the diagnosis than you think!. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(4): 839-841

Kowalski, C.J.; Schneiderman, E.D.; Willis, S.M. 1994: ANCOVA for nonparallel slopes: The Johnson-Neyman technique. International Journal of Bio-Medical Computing 37(3): 273-286

Köhler, A.; Schmidt-Zachmann, M.S.; Franke, W.W. 1997: AND-1, a natural chimeric DNA-binding protein, combines an HMG-box with regulatory WD-repeats. Journal of Cell Science 110: 1051-1062

Garcia, N.H.; Garvin, J.L. 1995: ANF and angiotensin II interact via kinases in the proximal straight tubule. American Journal of Physiology 268(4 Pt 2): F730-F735

Cerra, M.C.; Canonaco, M.; Tota, B. 1993: ANF binding sites in the heart of the quail (Coturnix coturnix japonica). Peptides 14(5): 913-918

Olivera, W.; Ridge, K.; Wood, L.D.; Sznajder, J.I. 1993: ANF decreases active sodium transport and increases alveolar epithelial permeability in rats. Journal of Applied Physiology 75(4): 1581-1586

Wyatt, T.A.; Naftilan, A.J.; Francis, S.H.; Corbin, J.D. 1998: ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. American Journal of Physiology 274(2): H448-H455

Garvin, J.L. 1992: ANF inhibits norepinephrine-stimulated fluid absorption in rat proximal straight tubules. American Journal of Physiology 263(4 Pt 2): F581-F585

Perreault, T.; Baribeau, J.; Gutkowska, J. 1997: ANF system in the newborn piglet pulmonary vessels. Journal of Cardiovascular Pharmacology 29(6): 740-746

Cahill, P.A.; Hassid, A. 1994: ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity. American Journal of Physiology 266(1 Pt 2): R194-R203

Liakos, P.; Bourmeyster, N.; Defaye, G.; Chambaz, E.M.; Bottari, S.P. 1997: ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells. American Journal of Physiology 273(4): C1324-C1334

Bai, D.; Renaud, L.P. 1998: ANG Ii AT1 receptors induce depolarization and inward current in rat median preoptic neurons in vitro. American Journal of Physiology 275(2): R632-R639

Iversen, B.M.; Arendshorst, W.J. 1998: ANG Ii and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. American Journal of Physiology 274(3): F498-F508

Amlal, H.; LeGoff, C.; Vernimmen, C.; Soleimani, M.; Paillard, M.; Bichara, M. 1998: ANG II controls Na(+)-K+(NH4+)-2Cl- cotransport via 20-HETE and PKC in medullary thick ascending limb. American Journal of Physiology 274(4): C1047-C1056

Mitchell, K.D.; Mullins, J.J. 1995: ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. American Journal of Physiology 268(5 Pt 2): F821-F828

Wolf, G.; Ziyadeh, F.N.; Helmchen, U.; Zahner, G.; Schroeder, R.; Stahl, R.A. 1995: ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. American Journal of Physiology 268(5 Pt 2): F940-F947

Horackova, M.; Armour, J.A. 1997: ANG Ii modifies cardiomyocyte function via extracardiac and intracardiac neurons: in situ and in vitro studies. American Journal of Physiology 272(3 Part 2): R766-R775

Johansson, B.; Holm, M.; Chen, L.; Pettersson, A.; Jönson, C.; Fändriks, L. 1997: ANG Ii prolongs splanchnic nerve-mediated inhibition of duodenal mucosal alkaline secretion in the rat. American Journal of Physiology 273(3 Part 2): R942-R946

DiBona, G.F.; Jones, S.Y.; Brooks, V.L. 1995: ANG Ii receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. American Journal of Physiology 269(5 Part 2): R1189-R1196

Rockman, H.A.; Wachhorst, S.P.; Mao, L.; Ross, J. 1994: ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. American Journal of Physiology 266(6 Pt 2): H2468-H2475

Corriu, C.; André, P.; Schott, C.; Michel, M.; Stoclet, J.C. 1994: ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells. American Journal of Physiology 266(2 Pt 2): H631-H636

Reiss, K.; Capasso, J.M.; Huang, H.E.; Meggs, L.G.; Li, P.; Anversa, P. 1993: ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. American Journal of Physiology 264(3 Pt 2): H760-H769

Olson, S.C.; Dowds, T.A.; Pino, P.A.; Barry, M.T.; Burke-Wolin, T. 1997: ANG Ii stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium. American Journal of Physiology 273(2 Part 1): L315-L321

Stouffer, G.A.; Shimizu, R.T.; Turla, M.B.; Owens, G.K. 1993: ANG II- or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. American Journal of Physiology 264(2 Pt 1): C390-C395

Levine, D.Z.; Iacovitti, M.; Buckman, S.; Hincke, M.T.; Luck, B.; Fryer, J.N. 1997: ANG II-dependent HCO3- reabsorption in surviving rat distal tubules: expression/activation of H(+)-ATPase. American Journal of Physiology 272(6 Pt 2): F799-F808

Freeman, E.J.; Ruehr, M.L.; Dorman, R.V. 1998: ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. American Journal of Physiology 274(1): C282-C288

Henegar, J.R.; Schwartz, D.D.; Janicki, J.S. 1998: ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation. American Journal of Physiology 275(2): H534-H541

Stolworthy, L.D.; Shirts, R.B. 1997: ANLIZE: A molecular mechanics force field visualization tool and its application to 18-crown-6. Journal of Computer-Aided Molecular Design 11(2): 129-134

Mirto, S.; Santoro, A.; Barbata, G.; Crescimanno, A.; Buscemi, F.; Carbone, P.; Caronia, F. 1992: ANLL patients with normal karyotype are not a homogeneous prognostic group. Haematologica 77(6): 484-486

Hamilton, D.J.; Thomson, D.C.; Sandham, W.A. 1995: ANN Compression of morphologically similar ECG complexes. Medical and Biological Engineering and Computing 33(6): 841-843

Vijaya, G.; Kumar, V.; Verma, H.K. 1998: ANN-based QRS-complex analysis of ECG. Journal of Medical Engineering and Technology 22(4): 160-167

Recknagel, F. 1997: ANNA - Artificial neural network model for predicting species abundance and succession of blue-green algae. Hydrobiologia 349: 47-57

Weerahandi, S. 1995: ANOVA under unequal error variances. Biometrics 51(2): 589-599

Thomas, C.J.; Head, G.A.; Woods, R.L. 1998: ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy. Hypertension 32(3): 548-555

Antunes-Rodrigues, J.; Favaretto, A.L.; Ballejo, G.; Gutkowska, J.; McCann, S.M. 1996: ANP as a neuroendocrine modulator of body fluid homeostasis. Revista Brasileira de Biologia 56(1 Suppl Part 2): 221-231

Papadopoulos, C.L.; Kokkas, B.A.; Sakadamis, G.C.; Kanonidis, I.E.; Kotridis, P.S.; Karamouzis, M.I.; Koukoulekidis, G.N.; Nikolaidis, N.K.; Missopoulou-Kokka, A.; Gitsios, C.T. 1997: ANP concentrations during interchanging DDD-VVi pacing modes in patients with retrograde ventriculoatrial conduction. Acta Cardiologica 52(1): 37-47

Thomas, C.J.; Rankin, A.J.; Head, G.A.; Woods, R.L. 1997: ANP enhances bradycardic reflexes in normotensive but not spontaneously hypertensive rats. Hypertension 29(5): 1126-1132

Pfeifer, M.; Wolf, K.; Blumberg, F.C.; Elsner, D.; Muders, F.; Holmer, S.R.; Riegger, G.A.; Kurtz, A. 1997: ANP gene expression in rat hearts during hypoxia. Pflugers Archiv: European Journal of Physiology 434(1): 63-69

Atchison, D.J.; Pennefather, P.S.; Ackermann, U. 1993: ANP has no postsynaptic effect on autonomic regulation of cardiac pacemaker rate in the rat. American Journal of Physiology 265(6 Part 2): H1983-H1987

McKay, M.K.; Huxley, V.H. 1995: ANP increases capillary permeability to protein independent of perfusate protein composition. American Journal of Physiology 268(3 Part 2): H1139-H1148

Argenzio, R., A.; Armstrong, M. 1993: ANP inhibits sodium chloride absorption and elicits chlorine secretion in porcine colon: Evidence for cGMP and calcium mediation. American Journal of Physiology 265(1 Part 2): R57-R65

Lee, Young Man 1997: ANP inhibits surfactant secretion from isoproterenol stimulated alveolar type II cells. Korean Journal of Physiology and Pharmacology 1(1): 65-70

Iervasi, G.; Clerico, A.; Berti, S.; Pilo, A.; Vitek, F.; Biagini, A.; Baratto, M.T.; Bianchi, R.; Donato, L. 1993: ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake. American Journal of Physiology 264(3 Pt 2): F480-F489

Hempel, A.; Friedrich, M.; Schlüter, K.D.; Forssmann, W.G.; Kuhn, M.; Piper, H.M. 1997: ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes. American Journal of Physiology 273(1 Part 2): H244-H249

Tang, W.; Paulding, W.R.; Sumners, C. 1993: ANP receptors in neurons and astrocytes from spontaneously hypertensive rat brain. American Journal of Physiology 265(1 Pt 1): C106-C112

Wigle, D.A.; Campling, B.G.; Sarda, I.R.; Shin, S.H.; Watson, J.D.; Frater, Y.; Flynn, T.G.; Pang, S.C. 1995: ANP secretion from small cell lung cancer cell lines: a potential model of ANP release. American Journal of Physiology 268(5 Pt 2): H1869-H1874

Mazarati, A.M.; Halászi, E.; Telegdy, G.; Tóth, G.; Varga, J. 1993: ANP(1-28), BNP(1-32) and CNP(1-22) increase the severity of picrotoxin-kindled seizure syndrome in rats. Life Sciences 52(3): PL19-PL24

Lim, A.T.; Dow, R.C.; Yang, Z.; Fink, G. 1994: ANP(5-28) is the major molecular species in hypophysial portal blood of the rat. Peptides 15(8): 1557-1559

Millul, V.; Prié, D.; Géniteau-Legendre, M.; Verpont, M.C.; Baudouin, B.; Ronco, P.M. 1996: ANP-stimulated cGMP egression in renal principal cells: abrogation of polarity by SV40 large T. American Journal of Physiology 270(4 Part 1): C1051-C1060

Nedospasov, A.A.; Lifanov, A.P.; Rodina, E.V. 1994: ANSA-analysis. I. Substrate mixtures in the analysis of proteases. Biokhimiya 59(10): 1511-1520

Trushkin, A.M.; Kazantsev, A.G.; Kuznetsov, N.V.; Yakhimovich, A.D.; Moguchaya, G.Y.; Rodina, E.V.; Gridneva, N.A.; Sharina, I.G.; Nedospasov, A.A. 1994: ANSA-analysis. II. Aminonaphthalenesulfonamides as detectable groups for polysubstrate analysis of proteases. Biokhimiya 59(10): 1521-1534

Kazantsev, A.G.; Kuznetsov, N.V.; Iakhimovich, A.D.; Sharina, I.G.; Nezavibat'ko, V.N.; Nedospasov, A.A. 1994: ANSA analysis. III. Synthesis of aminonaphthalinesulfonamide chromogenic substrates for protease analysis. Biokhimiia 59(10): 1535-1543

Rodina, E.V.; Cherkasov, A.V.; Nedospasov, A.A. 1994: ANSA-analysis. IV. Specificity spectra in characterization of proteases and their mixtures. Biokhimiya 59(10): 1544-1559

Nedospasov, A.A.; Rodina, E.V.; Cherkasov, A.V. 1994: ANSA-analysis. V. Secondary specificity of peptidases for the structure of detectable groups of aminonaphthalenesulfonamide chromogenic substrates. Biokhimiya 59(10): 1560-1573

Nelson, T., J.; Wilmes, D., P.; Daroza, R., A. 1994: ANSI Z88.2 (1992): Practices for respiratory protection. American Industrial Hygiene Association Journal 55(7): 660-662

Toder, R.; Rappold, G.A.; Schiebel, K.; Schempp, W. 1995: ANT3 and STS are autosomal in prosimian lemurs: Implications for the evolution of the pseudoautosomal region. Human Genetics 95(1): 22-28

Flinkkilä, T.; Raatikainen, T.; Hämäläinen, M. 1998: AO and Frykman's classifications of Colles' fracture. No prognostic value in 652 patients evaluated after 5 years. Acta Orthopaedica Scandinavica 69(1): 77-81

White, D.R.; Lechevallier, M.W. 1993: AOC associated with oils for lubricating well pumps. Journal - American Water Works Association 85(8): 112-114

Wachman, E.S.; Niu, W.; Farkas, D.L. 1997: AOTF microscope for imaging with increased speed and spectral versatility. Biophysical Journal 73(3): 1215-1222

Francis, D.W.; Turner, P.A.; Wearing, J.T. 1997: AOX reduction of kraft bleach plant effluent by chemical pretreatment: Pilot-scale trials. Water Research 31(10): 2397-2404

Kümmerer, K.; Erbe, T.; Gartiser, S.; Brinker, L. 1998: AOX-emissions from hospitals into municipal waste water. Chemosphere 36(11): 2437-2445

Redaelli, A.; Magrassi, R.; Bonassi, S.; Abbondandolo, A.; Frosina, G. 1998: AP endonuclease activity in humans: Development of a simple assay and analysis of ten normal individuals. Teratogenesis Carcinogenesis and Mutagenesis 18(1): 17-26

Auwerx, J.; Sassone-Corsi, P. 1992: AP-1 (Fos-Jun) regulation by IP-1: effect of signal transduction pathways and cell growth. Oncogene 7(11): 2271-2280

Ying, Z.; Reisman, D.; Buggy, J. 1996: AP-1 DNA binding activity induced by hyperosmolality in the rat hypothalamic supraoptic and paraventricular nuclei. Brain Research. Molecular Brain Research 39(1-2): 109-116

Spyrou, G.; Björnstedt, M.; Kumar, S.; Holmgren, A. 1995: AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. Febs Letters 368(1): 59-63

Rosson, D.; O'Brien, T.G. 1998: AP-1 activity affects the levels of induced erythroid and megakaryocytic differentiation of K562 cells. Archives of Biochemistry and Biophysics 352(2): 298-305

Briata, P.; D'Anna, F.; Franzi, A.T.; Gherzi, R. 1993: AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding. Experimental Cell Research 204(1): 136-146

Botteron, C.; Dobbelaere, D. 1998: AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells. Biochemical and Biophysical Research Communications 246(2): 418-421

Lukasiuk, K.; Kaczmarek, L. 1994: AP-1 and CRE DNA binding activities in rat brain following pentylenetetrazole induced seizures. Brain Research 643(1-2): 227-233

Beckmann, A.M.; Matsumoto, I.; Wilce, P.A. 1997: AP-1 and Egr DNA-binding activities are increased in rat brain during ethanol withdrawal. Journal of Neurochemistry 69(1): 306-314

Sark, M.W.; Fischer, D.F.; de Meijer, E.; van de Putte, P.; Backendorf, C. 1998: AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker. Journal of Biological Chemistry 273(38): 24683-24692

Delhase, M.; Castrillo, J.L.; de la Hoya, M.; Rajas, F.; Hooghe-Peters, E.L. 1996: AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. Journal of Biological Chemistry 271(50): 32349-32358

Pospelov, V.A.; Pospelova, T.V.; Julien, J.P. 1994: AP-1 and Krox-24 transcription factors activate the neurofilament light gene promoter in P19 embryonal carcinoma cells. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 5(2): 187-196

Wondisford, F.E.; Steinfelder, H.J.; Nations, M.; Radovick, S. 1993: AP-1 antagonizes thyroid hormone receptor action on the thyrotropin beta-subunit gene. Journal of Biological Chemistry 268(4): 2749-2754

Pedraza-Alva, G.; Zingg, J.M.; Jost, J.P. 1994: AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblasts. Journal of Biological Chemistry 269(9): 6978-6985

Zhu, J.; Aurelian, L. 1997: AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). Virology 231(2): 301-312

Kralova, J.; Liss, A.S.; Bargmann, W.; Bose, H.R. 1998: AP-1 factors play an important role in transformation induced by the v-rel oncogene. Molecular and Cellular Biology 18(5): 2997-3009

Trocmé, C.; Mallet, J.; Biguet, N.F. 1997: AP-1 mediates trans-synaptic induction of tyrosine hydroxylase gene expression in adrenal medulla but not in superior cervical ganglia. Journal of Neuroscience Research 48(6): 489-498

López-Rodríguez, C.; Kluin-Nelemans, H.C.; Corbí, A.L. 1996: AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. Journal of Immunology 156(10): 3780-3787

Yamauchi, M.; Ogata, Y.; Kim, R.H.; Li, J.J.; Freedman, L.P.; Sodek, J. 1996: AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter. Matrix Biology: Journal of the International Society for Matrix Biology 15(2): 119-130

Tümer, N.; Scarpace, P.J.; Baker, H.V.; Larochelle, J.S. 1997: AP-1 transcription factor binding activity in rat adrenal medulla and hypothalamus with age and cold exposure. Neuropharmacology 36(8): 1065-1069

Hirota, K.; Matsui, M.; Iwata, S.; Nishiyama, A.; Mori, K.; Yodoi, J. 1997: AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proceedings of the National Academy of Sciences of the United States of America 94(8): 3633-3638

Rincón, M.; Flavell, R.A. 1994: AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO Journal 13(18): 4370-4381

Ghee, M.; Baker, H.; Miller, J.C.; Ziff, E.B. 1998: AP-1, CREB and CBP transcription factors differentially regulate the tyrosine hydroxylase gene. Brain Research. Molecular Brain Research 55(1): 101-114

Lamb, R.F.; Hennigan, R.F.; Turnbull, K.; Katsanakis, K.D.; MacKenzie, E.D.; Birnie, G.D.; Ozanne, B.W. 1997: AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Molecular and Cellular Biology 17(2): 963-976

Macarthur, L. 1996: AP-1-related proteins bind to the enkephalin CRE-2 element in adrenal chromaffin cells. Journal of Neurochemistry 67(6): 2256-2264

Dong, Z.; Xu, R.H.; Kim, J.; Zhan, S.N.; Ma, W.Y.; Colburn, N.H.; Kung, H. 1996: AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin. Journal of Biological Chemistry 271(17): 9942-9946

Derigs, H.G.; Morgan, D.A.; Hoffman, R.; Litz, S.L.; Srour, E.F.; Brandt, J.E.; Boswell, H.S. 1995: AP-1/C-jun and C-myc Regulation During Megakaryocytic Differentiation of a Human Bi-potential Growth-factor-dependent Cell Line. Platelets 6(1): 24-30

Wanner, R.; Zhang, J.; Henz, B.M.; Rosenbach, T. 1996: AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation. Biochemical and Biophysical Research Communications 223(3): 666-669

Traub, L.M.; Bannykh, S.I.; Rodel, J.E.; Aridor, M.; Balch, W.E.; Kornfeld, S. 1996: AP-2-containing clathrin coats assemble on mature lysosomes. Journal of Cell Biology 135(6 Pt 2): 1801-1814

Chazaud, C.; Oulad-Abdelghani, M.; Bouillet, P.; Décimo, D.; Chambon, P.; Dollé, P. 1996: AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mechanisms of Development 54(1): 83-94

Oulad-Abdelghani, M.; Bouillet, P.; Chazaud, C.; Dollé, P.; Chambon, P. 1996: AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Experimental Cell Research 225(2): 338-347

Benmerah, A.; Lamaze, C.; Bègue, B.; Schmid, S.L.; Dautry-Varsat, A.; Cerf-Bensussan, N. 1998: AP-2/Eps15 interaction is required for receptor-mediated endocytosis. Journal of Cell Biology 140(5): 1055-1062

Dell'Angelica, E.C.; Ohno, H.; Ooi, C.E.; Rabinovich, E.; Roche, K.W.; Bonifacino, J.S. 1997: AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO Journal 16(5): 917-928

Hou, Y.T.; Coleman, T.A.; Kopchick, J.J. 1995: AP-4- and AP-5-like proteins from mouse L cells are trans-activators and bind to the GT-II region of SV40 early TRE in a mutually exclusive manner. Gene 162(2): 197-203

Wimmer, C.; Gluch, H.; Krismer, M.; Ogon, M.; Jesenko, R. 1997: AP-translation in the proximal disc adjacent to lumbar spine fusion. A retrospective comparison of mono- and polysegmental fusion in 120 patients. Acta Orthopaedica Scandinavica 68(3): 269-272

Guo, W.; Tang, W.J.; Bu, X.; Bermudez, V.; Martin, M.; Folk, W.R. 1996: AP1 enhances polyomavirus DNA replication by promoting T-antigen-mediated unwinding of DNA. Journal of Virology 70(8): 4914-4918

Swanson, D.J.; Zellmer, E.; Lewis, E.J. 1998: AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene. Journal of Biological Chemistry 273(37): 24065-24074

Jacobs-Helber, S.M.; Wickrema, A.; Birrer, M.J.; Sawyer, S.T. 1998: AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Molecular and Cellular Biology 18(7): 3699-3707

Alarco, A.M.; Balan, I.; Talibi, D.; Mainville, N.; Raymond, M. 1997: AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. Journal of Biological Chemistry 272(31): 19304-19313

Chae, H.D.; Suh, B.C.; Joh, T.H.; Kim, K.T. 1996: AP1-mediated transcriptional enhancement of the rat tyrosine hydroxylase gene by muscarinic stimulation. Journal of Neurochemistry 66(3): 1264-1272

Murakami, K..; Li, Y.. 1996: AP1-related factors interact with simian immunodeficiency virus long terminal repeats. Journal of Biomedical Science 3(3): 170-177

Sun, Q.; Disher, M.J.; Rustad, T.; Telian, S.A.; Andrews, P.C. 1998: AP30, a differential protein marker for perilymph and cerebrospinal fluid in middle ear fluid, has been purified and identified as human apolipoprotein D. Biochimica Et Biophysica Acta 1384(2): 405-413

Trommer, B.L.; Kennelly, J.J.; Colley, P.A.; Overstreet, L.S.; Slater, N.T.; Pasternak, J.F. 1995: AP5 blocks LTP in developing rat dentate gyrus and unmasks LTD. Experimental Neurology 131(1): 83-92

Tan, I.K. 1998: APACHE Ii and SAPS Ii are poorly calibrated in a Hong Kong intensive care unit. Annals of the Academy of Medicine Singapore 27(3): 318-322

Lertakyamanee, J.; Somprakit, P.; Vorakitpokaton, P.; Kururattapan, S.A.; Udompunturak, S.; Pensuk, S. 1997: APACHE Ii in a postoperative intensive care unit in Thailand. Journal of the Medical Association of Thailand 80(3): 169-177

Demarco, P.J.; Powers, M.K. 1994: APB alters photopic spectral sensitivity of the goldfish retina. Vision Research 34(1): 1-9

Aoki, T.; Takeda, S.; Yanagisawa, A.; Kato, Y.; Ajioka, Y.; Watanabe, H.; Kudo, S.; Nakamura, Y. 1994: APC and p53 mutations in de novo colorectal adenocarcinomas. Human Mutation 3(4): 342-346

Su, L.K.; Burrell, M.; Hill, D.E.; Gyuris, J.; Brent, R.; Wiltshire, R.; Trent, J.; Vogelstein, B.; Kinzler, K.W. 1995: APC binds to the novel protein EB1. Cancer Research 55(14): 2972-2977

Midgley, C.A.; White, S.; Howitt, R.; Save, V.; Dunlop, M.G.; Hall, P.A.; Lane, D.P.; Wyllie, A.H.; Bubb, V.J. 1997: APC expression in normal human tissues. Journal of Pathology 181(4): 426-433

Oshima, M.; Sugiyama, H.; Kitagawa, K.; Taketo, M. 1993: APC gene messenger RNA: novel isoforms that lack exon 7. Cancer Research 53(23): 5589-5591

Achille, A.; Scupoli, M.T.; Magalini, A.R.; Zamboni, G.; Romanelli, M.G.; Orlandini, S.; Biasi, M.O.; Lemoine, N.R.; Accolla, R.S.; Scarpa, A. 1996: APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis. International Journal of Cancer 68(3): 305-312

Giardiello, F.M.; Petersen, G.M.; Piantadosi, S.; Gruber, S.B.; Traboulsi, E.I.; Offerhaus, G.J.; Muro, K.; Krush, A.J.; Booker, S.V.; Luce, M.C.; Laken, S.J.; Kinzler, K.W.; Vogelstein, B.; Hamilton, S.R. 1997: APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 40(4): 521-525

Watanabe, M.; Kakiuchi, H.; Kato, H.; Shiraishi, T.; Yatani, R.; Sugimura, T.; Nagao, M. 1996: APC gene mutations in human prostate cancer. Japanese Journal of Clinical Oncology 26(2): 77-81

Powell, S.M.; Papadopoulos, N.; Kinzler, K.W.; Smolinski, K.N.; Meltzer, S.J. 1994: APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 107(6): 1759-1763

Béroud, C.; Soussi, T. 1996: APC gene: Database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Research 24(1): 121-124

Almeida, R.; Morton, N.; Fidalgo, P.; Leitão, N.; Mira, C.; Rueff, J.; Monteiro, C. 1996: APC intragenic haplotypes in familial adenomatous polyposis. Clinical Genetics 50(6): 483-485

Huang, J.; Zheng, S.; Jin, S. 1996: APC mutation analysis in sporadic colorectal cancer. Zhonghua Zhong Liu Za Zhi 18(6): 415-418

Bjerknes, M.; Cheng, H.; Hay, K.; Gallinger, S. 1997: APC mutation and the crypt cycle in murine and human intestine. American Journal of Pathology 150(3): 833-839

Smith-Ravin, J.; Pack, K.; Hodgson, S.; Tay, S.K.; Phillips, R.; Bodmer, W. 1994: APC mutation associated with late onset of familial adenomatous polyposis. Journal of Medical Genetics 31(11): 888-890

van der Luijt, R.B.; Vasen, H.F.; Tops, C.M.; Breukel, C.; Fodde, R.; Meera Khan, P. 1995: APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Human Genetics 96(6): 705-710

Huang, J.; Papadopoulos, N.; McKinley, A.J.; Farrington, S.M.; Curtis, L.J.; Wyllie, A.H.; Zheng, S.; Willson, J.K.; Markowitz, S.D.; Morin, P.; Kinzler, K.W.; Vogelstein, B.; Dunlop, M.G. 1996: APC mutations in colorectal tumors with mismatch repair deficiency. Proceedings of the National Academy of Sciences of the United States of America 93(17): 9049-9054

Armstrong, J.G.; Davies, D.R.; Guy, S.P.; Frayling, I.M.; Evans, D.G. 1997: APC mutations in familial adenomatous polyposis families in the Northwest of England. Human Mutation 10(5): 376-380

Mulkens, J.; Poncin, J.; Arends, J.W.; De Goeij, A.F. 1998: APC mutations in human colorectal adenomas: analysis of the mutation cluster region with temperature gradient gel electrophoresis and clinicopathological features. Journal of Pathology 185(4): 360-365

Lamparter, S.; Schuermann, M.; Heidtmann, H.H. 1997: APC resistance as an additional thrombotic risk factor in a patient suffering from polycythemia vera and recurrent thrombosis. Annals of Hematology 74(1): 49-50

Hilberg, T.; Moessmer, G.; Hartard, M.; Jeschke, D. 1998: APC resistance in an elite female athlete. Medicine and Science in Sports and Exercise 30(2): 183-184

Nowak-Göttl, U.; Kohlhase, B.; Vielhaber, H.; Aschka, I.; Schneppenheim, R.; Jürgens, H. 1996: APC resistance in neonates and infants: adjustment of the APTT-based method. Thrombosis Research 81(6): 665-670

Nishio, I.; Mishima, H.; Yagyu, T.; Ikenaga, M.; Takemasa, I. 1997: APC tumor suppressor gene. Stomach and Intestine 32(4): 601-606

Itoi, T.; Watanabe, H.; Ajioka, Y.; Oohashi, Y.; Takel, K.; Nishikura, K.; Nakamura, Y.; Horil, A.; Saito, T. 1996: APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathology International 46(5): 333-340

Juang, Y.L.; Huang, J.; Peters, J.M.; McLaughlin, M.E.; Tai, C.Y.; Pellman, D. 1997: APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle. Science 275(5304): 1311-1314

Hoagland, L.E.; Triplett, D.A.; Peng, F.; Barna, L. 1996: APC-resistance as measured by a textarin time assay: Comparison to the APTT-based method. Thrombosis Research 83(5): 363-373

Winkler, U.H. 1997: APC-resistance, antithrombin III-deficiency and protein C- or S-deficiency. Geburtshilfe und Frauenheilkunde 57(1): 7-14

Marks, N.J.; Maule, A.G.; Geary, T.G.; Thompson, D.P.; Davis, J.P.; Halton, D.W.; Verhaert, P.; Shaw, C. 1997: APEASPFIRFamide, a novel FMRFamide-related decapeptide from Caenorhabditis elegans: structure and myoactivity. Biochemical and Biophysical Research Communications 231(3): 591-595

Hsieh, C.M.; Yoshizumi, M.; Endege, W.O.; Kho, C.J.; Jain, M.K.; Kashiki, S.; de los Santos, R.; Lee, W.S.; Perrella, M.A.; Lee, M.E. 1996: APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury. Journal of Biological Chemistry 271(29): 17354-17359

Lafont, H.; Domingo, N.; Groen, A.; Kaler, E.W.; Lee, S.P.; Koehler, R.; Ostrow, J.D.; Veis, A. 1997: APF/CBP, the small, amphipathic, anionic protein(s) in bile and gallstones, consists of lipid-binding and calcium-binding forms. Hepatology 25(5): 1054-1063

Zivanovic, D.; Susic, V.; Stanojlovic, O. 1997: APH, an N-methyl-D-aspartate receptor antagonist, blocks the metaphit-induced audiogenic seizures in rats. Journal of Physiology Paris 91(6): 317-323,.

Fidalgo, M.L.; Alonso, J.L.; Soliveri, J.; Arias, M.E. 1992: APHE-1 and APHE-2, two new antimicrobial and cytotoxic antibiotics. I. Taxonomy, fermentation, isolation and biological activity. Journal of Antibiotics 45(11): 1753-1758

Fidalgo, M.L.; Arias, M.S.; Soliveri, J.; Arias, M.E. 1992: APHE-1 and APHE-2, two new antimicrobial and cytotoxic antibiotics. II. Physico-chemical properties and structure elucidation. Journal of Antibiotics 45(11): 1759-1762

Iliadis, A.; Brown, A.C.; Huggins, M.L. 1992: APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics. Computer Methods and Programs in Biomedicine 38(4): 227-239

Alvarruiz, A.; Gutierrez, A.; Rodrigo, M. 1992: APL program for evaluation of heat processes for spherical foods. Computer Applications in the Biosciences: Cabios 8(6): 549-554

Stefanini, F.M.; Camussi, A. 1993: APLOGEN: an object-oriented genetic algorithm performing Monte Carlo optimization. Computer Applications in the Biosciences: Cabios 9(6): 695-700

Reuter, S.; Bartelmann, M.; Vogt, M.; Geisen, C.; Napierski, I.; Kahn, T.; Delius, H.; Lichter, P.; Weitz, S.; Korn, B.; Schwarz, E. 1998: APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO Journal 17(1): 215-222

Galazka, G.; Windsor, L.J.; Birkedal-Hansen, H.; Engler, J.A. 1996: APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. Biochemistry 35(34): 11221-11227

Alavantić, D.; Glisić, S.; Kandić, I. 1998: APO B 3' HVR polymorphism in healthy population: relationships to serum lipid levels. Genetic Epidemiology 15(2): 113-122

Duly, E.B.; Ward, A.J.; Kirk, C.W.; Nevin, N.C.; Trinick, T.R.; Nicholls, D.P.; Young, I.S.; Graham, C.A. 1997: APO e genotype and familial hypercholesterolaemia. Annals of Clinical Biochemistry 34: 534-536

Valveny, N.; Esteban, E.; Kandil, M.; Moral, P. 1997: APO E polymorphism in Spanish and Moroccan populations. Clinical Genetics 51(5): 354-356

Lücking-Famira, K.M.; Daniel, P.T.; Möller, P.; Krammer, P.H.; Debatin, K.M. 1994: APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. Leukemia 8(11): 1825-1833

Mapara, M.Y.; Bargou, R.; Zugck, C.; Döhner, H.; Ustaoglu, F.; Jonker, R.R.; Krammer, P.H.; Dörken, B. 1993: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. European Journal of Immunology 23(3): 702-708

Schraven, B.; Peter, M.E. 1995: APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Letters 368(3): 491-494

Debatin, K.M.; Goldman, C.K.; Waldmann, T.A.; Krammer, P.H. 1993: APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81(11): 2972-2977

Rieger, J.; Naumann, U.; Glaser, T.; Ashkenazi, A.; Weller, M. 1998: APO2 ligand: A novel lethal weapon against malignant glioma?. FEBS Letters 427(1): 124-128

Sulkava, R.; Kainulainen, K.; Verkkoniemi, A.; Niinistö, L.; Sobel, E.; Davanipour, Z.; Polvikoski, T.; Haltia, M.; Kontula, K. 1996: APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. Neurobiology of Aging 17(3): 373-376

Van Broeckhoven, C.; Backhovens, H.; Cruts, M.; Martin, J.J.; Crook, R.; Houlden, H.; Hardy, J. 1994: APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neuroscience Letters 169(1-2): 179-180

Albert, S.M.; Gurland, B.; Maestre, G.; Jacobs, D.M.; Stern, Y.; Mayeux, R. 1995: APOE genotype influences functional status among elderly without dementia. American Journal of Medical Genetics 60(6): 583-587

Chapman, J.; Cervenáková, L.; Petersen, R.B.; Lee, H.S.; Estupinan, J.; Richardson, S.; Vnencak-Jones, C.L.; Gajdusek, D.C.; Korczyn, A.D.; Brown, P.; Goldfarb, L.G. 1998: APOE in non-Alzheimer amyloidoses: transmissible spongiform encephalopathies. Neurology 51(2): 548-553

Cai, X.; Fallin, D.; Stanton, J.; Scibelli, P.; Duara, R.; Crawford, F.; Mullan, M. 1997: APOE is linked to Alzheimer's disease in a large pedigree. American Journal of Medical Genetics 74(4): 365-369

Kamboh, M.I.; Sanghera, D., K.; Ferrell, R., E.; Dekosky, S., T. 1995: APOE*4-associated Alzheimer's disease risk is modified by alpha-1-antichymotrypsin polymorphism. Nature Genetics 10(4): 486-488

Lombardi, V.R.; García, M.; Cacabelow, R. 1998: APOE-induced microglial activation: an in vitro assay to screen sera from Alzheimer's disease patients and novel therapeutic compounds. Methods and Findings in Experimental and Clinical Pharmacology 20(5): 377-386

Cacabelos, R.; Rodríguez, B.; Carrera, C.; Caamaño, J.; Beyer, K.; Lao, J.I.; Sellers, M.A. 1996: APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods and Findings in Experimental and Clinical Pharmacology 18(10): 693-706

Trieb, K.; Ransmayr, G.; Sgonc, R.; Lassmann, H.; Grubeck-Loebenstein, B. 1996: APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiology of Aging 17(4): 541-547

Zhan, S.S.; Sandbrink, R.; Beyreuther, K.; Schmitt, H.P. 1995: APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis. Clinical Neuropathology 14(3): 142-149

Schubert, W.; Masters, C.L.; Beyreuther, K. 1993: APP+ T lymphocytes selectively sorted to endomysial tubes in polymyositis displace NCAM-expressing muscle fibers. European Journal of Cell Biology 62(2): 333-342

Chow, N.; Korenberg, J.R.; Chen, X.N.; Neve, R.L. 1996: APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. Journal of Biological Chemistry 271(19): 11339-11346

Torroja, L.; Luo, L.; White, K. 1996: APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(15): 4638-4650

Bienfang, P., K.; Ziemann, D., A. 1995: APPRISE: A multi-year investigation of environment variation and its effects on larval recruitment. Canadian Special Publication of Fisheries and Aquatic Sciences 121: 483-487

Hahne, M.; Kataoka, T.; Schröter, M.; Hofmann, K.; Irmler, M.; Bodmer, J.L.; Schneider, P.; Bornand, T.; Holler, N.; French, L.E.; Sordat, B.; Rimoldi, D.; Tschopp, J. 1998: APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. Journal of Experimental Medicine 188(6): 1185-1190

Lee, S.; Leustek, T. 1998: APS kinase from Arabidopsis thaliana: genomic organization, expression, and kinetic analysis of the recombinant enzyme. Biochemical and Biophysical Research Communications 247(1): 171-175

Lau, K.C.; So, K.F.; Tay, D. 1992: APV prevents the elimination of transient dendritic spines on a population of retinal ganglion cells. Brain Research 595(1): 171-174

Murakami, K.; Yokoyama, H.; Onodera, K.; Iinuma, K.; Watanabe, T. 1995: AQ-0145, a newly developed histamine H3 antagonist, decreased seizure susceptibility of electrically induced convulsions in mice. Methods and Findings in Experimental and Clinical Pharmacology 17(Suppl): 70-73

Laskowski, R.A.; Rullmannn, J.A.; MacArthur, M.W.; Kaptein, R.; Thornton, J.M. 1996: AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR 8(4): 477-486

Myrdal, P., B.; Manka, A., M.; Yalkowsky, S., H. 1995: AQUAFAC 3: Aqueous functional group activity coefficients; application to the estimation of aqueous solubility. Chemosphere 30(9): 1619-1637

Pinsuwan, S.; Myrdal, P., B.; Lee, Y.-Chi; Yalkowsky, S., H. 1997: AQUAFAC 5: Aqueous functional group activity coefficients, application to alcohols and acids. Chemosphere 35(11): 2503-2513

Ström, A.C.; Ohlsson, P.; Akusjärvi, G. 1998: AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain. Journal of Virology 72(7): 5978-5983

Bertrand, V.; Bastié, M.J.; Bouisson, M.; Vaysse, N.; Pradayrol, L. 1996: AR4-2J cell line coexpresses dihydropyridine and omega-conotoxin sensitive Ca2+ channels. Cell Calcium 19(6): 495-500

Dietrich, J.B. 1996: AR4-2J cells: A model to study polypeptide hormone receptors. Bioscience Reports 16(4): 273-288

Parodi, A.; Rebora, A. 1997: ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus. Dermatology 194(3): 217-220

Kuss, B.J.; O'Neill, G.M.; Eyre, H.; Doggett, N.A.; Callen, D.F.; Davey, R.A. 1998: ARA, a novel ABC transporter, is located at 16p13.1, is deleted in inv(16) leukemias, and is shown to be expressed in primitive hematopoietic precursors. Genomics 51(3): 455-458

Koseki, T.; Inohara, N.; Chen, S.; Núñez, G. 1998: ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proceedings of the National Academy of Sciences of the United States of America 95(9): 5156-5160

Le Bihan, C.; Moutou, C.; Brugières, L.; Feunteun, J.; Bonaïti-Pellié, C. 1995: ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genetic Epidemiology 12(1): 13-25

Pinciroli, F.; Combi, C.; Pozzi, G. 1995: ARCADIA: A system for the integration of angiocardiographic data and images by an object-oriented DBMS. Computers and Biomedical Research An International Journal 28(1): 5-23

Morales Ramos, J.A.; Summy, K.R.; King, E.G. 1996: ARCASIM, a model to evaluate augmentation strategies of the parasitoid Catolaccus grandis against boll weevil populations. Ecological Modelling 93(1-3): 221-235

Claverie-Martin, F.; Wang, M.; Cohen, S.N. 1997: ARD-1 cDNA from human cells encodes a site-specific single-strand endoribonuclease that functionally resembles Escherichia coli RNase E. Journal of Biological Chemistry 272(21): 13823-13828

Vitale, N.; Moss, J.; Vaughan, M. 1996: ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain. Proceedings of the National Academy of Sciences of the United States of America 93(5): 1941-1944

Pluzanska, A.; Chmielowska, E.; Stempczynska, J.; Alwasiak, J.; Wrezel, B. 1995: ARDS (adult respiratory distress syndrome) after chemotherapy and radiotherapy: Complications after treatment in two patients with non Hodgkin's lymphoma. Acta Haematologica Polonica 26(2): 219-228

Loscar, M.; Hummel, T.; Haller, M.; Briegel, J.; Wiebecke, B.; Samtleben, W.; Berger, H.; Eichhorn, P.; Schelling, G. 1997: ARDS and Wegener's granulomatosis. A case report. Anaesthesist 46(11): 969-973

Argento, A.; DiBenedetto, R.J. 1998: ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome. Chest 113(4): 1136-1138

Jolliet, P.; Thorens, J.B.; Chevrolet, J.C. 1993: ARDS and mechanical ventilation--"primum nil nocere". Schweizerische Medizinische Wochenschrift 123(36): 1703-1714

Marenco, J.P.; Nervi, A.; White, A.C. 1998: ARDS associated with tumor lysis syndrome in a patient with non-Hodgkin's lymphoma. Chest 113(2): 550-552

Perren, A.; Beretta, F.; Schubarth, P. 1998: ARDS in plasmodium vivax malaria. Schweizerische Medizinische Wochenschrift 128(25): 1020-1023

Rabinovici, R.; Bugelski, P.J.; Esser, K.M.; Hillegass, L.M.; Vernick, J.; Feuerstein, G. 1993: ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. Journal of Applied Physiology 74(4): 1791-1802

Seeger, W.; Walmrath, D.; Grimminger, F. 1993: ARDS-new therapeutic aspects. Atemswegs- und Lungenkrankheiten 19(10): 472-491

Xie, T.; Belinsky, M.; Xu, Y.; Jaiswal, A.K. 1995: ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants. Journal of Biological Chemistry 270(12): 6894-6900

Acar, J.; Iung, B.; Boissel, J.P.; Samama, M.M.; Michel, P.L.; Teppe, J.P.; Pony, J.C.; Breton, H.L.; Thomas, D.; Isnard, R.; de Gevigney, G.; Viguier, E.; Sfihi, A.; Hanania, G.; Ghannem, M.; Mirode, A.; Nemoz, C. 1996: AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 94(9): 2107-2112

Gant, T.M.; Wilson, K.L. 1997: ARF is not required for nuclear vesicle fusion or mitotic membrane disassembly in vitro: evidence for a non-ARF GTPase in fusion. European Journal of Cell Biology 74(1): 10-19

Gaynor, E.C.; Chen, C.Y.; Emr, S.D.; Graham, T.R. 1998: ARF is required for maintenance of yeast Golgi and endosome structure and function. Molecular Biology of the Cell 9(3): 653-670

Shome, K.; Vasudevan, C.; Romero, G. 1997: ARF proteins mediate insulin-dependent activation of phospholipase D. Current Biology: Cb 7(6): 387-396

Loirand, G.; Cario-Toumaniantz, C.; Chardin, P.; Pacaud, P. 1997: ARF-independent inhibition of the carbachol-induced contractions by brefeldin A in intestinal smooth muscle. American Journal of Physiology 273(3 Pt 1): C816-C821

Arai, K.; Matsuda, T.; Sai, Y.; Ohkuma, S. 1998: ARF-induced lysosomal lysis in vitro. Journal of Biochemistry 123(4): 637-643

Szopa, J.; Sikorski, A.F. 1994: ARF-protein antisense potato displays stable ADP-ribosylation of 40 kDa protein. Journal of Plant Physiology 145(3): 383-386

Cockcroft, S. 1996: ARF-regulated phospholipase D: a potential role in membrane traffic. Chemistry and Physics of Lipids 80(1-2): 59-80

Whatmore, J.; Cronin, P.; Cockcroft, S. 1994: ARF1-regulated phospholipase D in human neutrophils is enhanced by PMA and MgATP. FEBS Letters 352(2): 113-117

D'Souza-Schorey, C.; van Donselaar, E.; Hsu, V.W.; Yang, C.; Stahl, P.D.; Peters, P.J. 1998: ARF6 targets recycling vesicles to the plasma membrane: Insights from an ultrastructural investigation. Journal of Cell Biology 140(3): 603-616

Manzella, L.; Barros, M.H.; Nobrega, F.G. 1998: ARH1 of Saccharomyces cerevisiae: a new essential gene that codes for a protein homologous to the human adrenodoxin reductase. Yeast 14(9): 839-846

Mishra, S.; Kumar, H.; Anand, V.K.; Patwari, A.K.; Sharma, D. 1993: ARI control programme: results in hospitalized children. Journal of Tropical Pediatrics 39(5): 288-292

Loeb, J.A.; Fischbach, G.D. 1995: ARIA Can Be Released from Extracellular Matrix through Cleavage of a Heparin-binding Domain. Journal of Cell Biology 130(1): 127-135

Sandrock, A.W.; Goodearl, A.D.; Yin, Q.W.; Chang, D.; Fischbach, G.D. 1995: ARIA is concentrated in nerve terminals at neuromuscular junctions and at other synapses. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(9): 6124-6136

Goodearl, A.D.; Yee, A.G.; Sandrock, A.W.; Corfas, G.; Fischbach, G.D. 1995: ARIA is concentrated in the synaptic basal lamina of the developing chick neuromuscular junction. Journal of Cell Biology 130(6): 1423-1434

Morley, B.J. 1998: ARIA is heavily expressed in rat peripheral auditory and vestibular ganglia. Brain Research. Molecular Brain Research 54(1): 170-174

Tansey, M.G.; Chu, G.C.; Merlie, J.P. 1996: ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway. Journal of Cell Biology 134(2): 465-476

Joubert, M.; Aymard, S.; Fieschi, D.; Volot, F.; Staccini, P.; Robert, J.J.; Fieschi, M. 1998: ARIANE: Integration of information databases within a hospital intranet. International Journal of Medical Informatics 49(3): 297-309

Dunn, J.; Hall, C.D.; Heath, M.R.; Mitchell, R.B.; Ritchie, B.J. 1993: ARIES: A system for concurrent physical, biological and chemical sampling at sea. Deep-Sea Research Part I Oceanographic Research Papers 40(4): 867-878

Plourde, P.V.; Dyroff, M.; Dowsett, M.; Demers, L.; Yates, R.; Webster, A. 1995: ARIMIDEX: a new oral, once-a-day aromatase inhibitor. Journal of Steroid Biochemistry and Molecular Biology 53(1-6): 175-179

Buzdar, A.U.; Jonat, W.; Howell, A.; Plourde, P.V. 1997: ARIMIDEX: A potent and selective aromatase inhibitor for the treatment of advanced breast cancer. Journal of Steroid Biochemistry and Molecular Biology 61(3-6): 145-149

Simmons, R.D.; Kaiser, F.C.; Pierson, M.E.; Rosamond, J.R. 1998: ARL 15849: A selective CCK-A agonist with anorectic activity in the rat and dog. Pharmacology Biochemistry and Behavior 59(2): 439-444

Greene, J.G.; Porter, R.H.; Greenamyre, J.T. 1996: ARL-15896, a novel N-methyl-D-aspartate receptor ion channel antagonist: neuroprotection against mitochondrial metabolic toxicity and regional pharmacology. Experimental Neurology 137(1): 66-72

Linko, P.; Rauman Aalto, P.; Moller, S.; Aarts, R.J.; Kortela, U. 1992: ARMAX modelling and stage estimation of an enzyme fermentation process. Chemical Engineering Journal 50(3): B45-B49

Yandava, C.N.; Zappulla, D.C.; Korf, B.R.; Neufeld, E.J. 1996: ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency. Journal of Clinical Laboratory Analysis 10(6): 414-417

Frank, S.; Upender, S.; Hansen, S.H.; Casanova, J.E. 1998: ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor 6. Journal of Biological Chemistry 273(1): 23-27

Franco, M.; Boretto, J.; Robineau, S.; Monier, S.; Goud, B.; Chardin, P.; Chavrier, P. 1998: ARNO3, a Sec7-domain guanine nucleotide exchange factor for ADP ribosylation factor 1, is involved in the control of Golgi structure and function. Proceedings of the National Academy of Sciences of the United States of America 95(17): 9926-9931

Schürmann, A.; Massmann, S.; Joost, H.G. 1995: ARP is a plasma membrane-associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation factors. Journal of Biological Chemistry 270(51): 30657-30663

Ivkovic, S.; Blau, S.; Polanskaya, O.; Ehrlich, M.E. 1996: ARPP-21: Murine gene structure and promoter identification of a neuronal phosphoprotein enriched in the limbic striatum. Brain Research 709(1): 10-16

Vandermeulen, J.H.; Singh, J.G. 1994: ARROW Oil Spill, 1970-90: Persistence of 20-yr Weathered Bunker C Fuel Oil. Canadian Journal of Fisheries and Aquatic Sciences 51(4): 845-855

Delouya, D.; Nobrega, F.G. 1993: ARS activity in the yeast mitochondrial genome of low-complexity petite mutants. Revista Brasileira de Genetica 16(1): 1-9

Borrego, E.; Yong, V.; Delgado, J. 1993: ARS activity of the suc 2 gene from S. cerevisiae in the methylotrophic yeast Pichia pastoris. Biotecnologia Aplicada 10(3): 194-199

Fong, T.M.; Mao, C.; MacNeil, T.; Kalyani, R.; Smith, T.; Weinberg, D.; Tota, M.R.; Van der Ploeg, L.H. 1997: ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochemical and Biophysical Research Communications 237(3): 629-631

Legro, R.S.; Shackleford, D.P.; Moessner, J.M.; Gnatuk, C.L.; Dodson, W.C. 1997: ART in women 40 and over. Is the cost worth it?. Journal of Reproductive Medicine 42(2): 76-82

Nikiforov, M.A.; Gudkov, A.V. 1994: ART-CH: a VL30 in chickens?. Journal of Virology 68(2): 846-853

Lemaitre, D.; Jaulent, M.C.; Günnel, U.; Demiris, A.M.; Michel, P.A.; Rassinoux, A.M.; Göransson, B.; Olsson, E.; Degoulet, P. 1994: ARTEMIS-2: an application development experiment with the HELIOS environment. Computer Methods and Programs in Biomedicine 45(Suppl): S127-S138

Rampazzo, A.; Nava, A.; Miorin, M.; Fonderico, P.; Pope, B.; Tiso, N.; Livolsi, B.; Zimbello, R.; Thiene, G.; Danieli, G.A. 1997: ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 45(2): 259-263

Strauss, R.G.; Burmeister, L.F.; Johnson, K.; James, T.; Miller, J.; Cordle, D.G.; Bell, E.F.; Ludwig, G.A. 1996: AS-1 red cells for neonatal transfusions: A randomized trial assessing donor exposure and safety. Transfusion 36(10): 873-878

Montero, R.; Gonsebatt, M.E.; Gerson, R.; Rojas, E.; Herrera, L.A.; Ostrosky-Wegman, P. 1993: AS-101: a modulator of in vitro T-cell proliferation. Anti-Cancer Drugs 4(3): 351-354

Kuroda, K.; Yoshida, M.; Uosaki, Y.; Ando, K.; Kawamoto, I.; Oishi, E.; Onuma, H.; Yamada, K.; Matsuda, Y. 1993: AS-183, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Scedosporium sp. SPC-15549. Journal of Antibiotics 46(8): 1196-1202

Wolters, U.; Wolf, T.; Stützer, H.; Schröder, T. 1996: ASA classification and perioperative variables as predictors of postoperative outcome. British Journal of Anaesthesia 77(2): 217-222

Jorgensen, N.H.; Messick, J.M.; Gray, J.; Nugent, M.; Berquist, T.H. 1994: ASA monitoring standards and magnetic resonance imaging. Anesthesia and Analgesia 79(6): 1141-1147

Kato, Y.; Komatsu, S. 1996: ASABF, a novel cysteine-rich antibacterial peptide isolated from the nematode Ascaris suum. Purification, primary structure, and molecular cloning of cDNA. Journal of Biological Chemistry 271(48): 30493-30498

Furesz, T.C.; Smith, C.H.; Moe, A.J. 1993: ASC system activity is altered by development of cell polarity in trophoblast from human placenta. American Journal of Physiology 265(1 Pt 1): C212-C217

Abel, S.; Nguyen, M.D.; Chow, W.; Theologis, A. 1995: ACS4, a primary indoleacetic acid-responsive gene encoding 1-aminocyclopropane-1-carboxylate synthase in Arabidopsis thaliana. Structural characterization, expression in Escherichia coli, and expression characteristics in response to auxin [corrected. Journal of Biological Chemistry 270(32): 19093-19099

Murphy, W.M. 1994: ASCP survey on anatomic pathology examination of the urinary bladder. American Journal of Clinical Pathology 102(6): 715-723

Zerangue, N.; Kavanaugh, M.P. 1996: ASCT-1 is a neutral amino acid exchanger with chloride channel activity. Journal of Biological Chemistry 271(45): 27991-27994

Yang, M.; Zachariah, S. 1997: ASCUS on cervical cytologic smears. Clinical significance. Journal of Reproductive Medicine 42(6): 329-331

Handfield, M.; Schweizer, H.P.; Mahan, M.J.; Sanschagrin, F.; Hoang, T.; Levesque, R.C. 1998: ASD-GFP vectors for in vivo expression technology in Pseudomonas aeruginosa and other gram-negative bacteria. Biotechniques 24(2): 261-264

The-American-Sleep-Disorders-Association-Standards-Of-Practice-Committee 1994: ASDA Standards of Practice: Practice Parameters for the Use of Stimulants in the Treatment of Narcolepsy. Sleep 17(4): 348-351

The-American-Sleep-Disorders-Association-Standards-Of-Practice-Committee 1994: ASDA Standards of Practice: Practice Parameters for the use of Portable Recording in the Assessment of Obstructive Sleep Apnea. Sleep 17(4): 372-377

Whitehead, C., M.; Winkfein, R., J.; Fritzler, M., J.; Rattner, J.B. 1997: ASE-1: A novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes. Chromosoma (Berlin) 106(8): 493-502

Gaertner, G. 1996: ASIB - the culture collection of algae at the Botanical Institute of the University at Innsbruck (Austria) catalogue of strains 1996. Berichte des Naturwissenschaftlich Medizinischen Vereins in Innsbruck 83: 45-69

Nishitoh, H.; Saitoh, M.; Mochida, Y.; Takeda, K.; Nakano, H.; Rothe, M.; Miyazono, K.; Ichijo, H. 1998: ASK1 is essential for JNK/SAPK activation by TRAF2. Molecular Cell 2(3): 389-395

Hollander, H., I.; Plumley, A., L.; Decesare, R., S. 1996: ASME/US Bureau of Mines investigative program on vitrification of combustion ash/residue: Findings and conclusions. Journal of Hazardous Materials 47(1-3): 369-381

Sinha, D.; Bakhshi, M.; Kunapuli, S.; Vora, R.; Gabriel, J.L.; Kirby, E.P.; Budzynski, A.Z. 1994: ASP514 within the A1 domain of bovine von Willebrand factor is required for interaction with platelet glycoprotein Ib. Biochemical and Biophysical Research Communications 203(2): 881-888

Milazzo, G.; Sciacca, L.; Papa, V.; Goldfine, I.D.; Vigneri, R. 1997: ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor. Molecular Carcinogenesis 18(1): 19-25

Anna, D.H.; Zellers, E.T.; Sulewski, R. 1998: ASTM F739 method for testing the permeation resistance of protective clothing materials: critical analysis with proposed changes in procedure and test-cell design. American Industrial Hygiene Association Journal 59(8): 547-556

Jansen, J.G.; van Teijlingen, C.M.; Mohn, G.R.; van Zeeland, A.A.; Vrieling, H. 1994: AT base pairs are the main target for mutations at the hprt locus of rat skin fibroblasts exposed in vitro to the monofunctional alkylating agent N-ethyl-N-nitrosourea. Mutagenesis 9(5): 417-421

Jenkins, T.C.; Lane, A.N. 1997: AT selectivity and DNA minor groove binding: modelling, NMR and structural studies of the interactions of propamidine and pentamidine with d(CGCGAATTCGCG)2. Biochimica et Biophysica Acta 1350(2): 189-204

Haywood, G.A.; Gullestad, L.; Katsuya, T.; Hutchinson, H.G.; Pratt, R.E.; Horiuchi, M.; Fowler, M.B. 1997: AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 95(5): 1201-1206

Wilcox, C.S.; Cardozo, J.; Welch, W.J. 1996: AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat. American Journal of Physiology 271(4 Pt 2): R891-R896

Sugimoto, K.; Gotoh, E.; Takasaki, I.; Ebina, T.; Iwamoto, T.; Takizawa, T.; Shionoiri, H.; Ishii, M. 1996: AT1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats. Clinical and Experimental Pharmacology and Physiology 23(4): 282-286

Worck, R.H.; Ibsen, H.; Frandsen, E.; Dige-Petersen, H. 1997: AT1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans. American Journal of Physiology 272(3 Pt 1): E415-E421

Walsh, D.A.; Suzuki, T.; Knock, G.A.; Blake, D.R.; Polak, J.M.; Wharton, J. 1994: AT1 receptor characteristics of angiotensin analogue binding in human synovium. British Journal of Pharmacology 112(2): 435-442

Iyer, S.N.; Raizada, M.K.; Katovich, M.J. 1996: AT1 receptor density changes during development of hypertension in hyperinsulinemic rats. Clinical and Experimental Hypertension 18(6): 793-810

Everett, A.D.; Heller, F.; Fisher, A. 1996: AT1 receptor gene regulation in cardiac myocytes and fibroblasts. Journal of Molecular and Cellular Cardiology 28(8): 1727-1736

Chodobski, A.; Szmydynger-Chodobska, J.; Vannorsdall, M.D.; Epstein, M.H.; Johanson, C.E. 1994: AT1 receptor subtype mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation in the rat. Regulatory Peptides 53(2): 123-129

D'Amico, M.; Di Filippo, C.; Berrino, L.; Rossi, F. 1997: AT1 receptors mediate pressor responses induced by angiotensin II in the periaqueductal gray area of rats. Life Sciences 61(1): Pl17-Pl20

Fitch, K.J.; Walsh, T.F.; Patchett, A.A.; Chang, R.S.L.; Siegl, P.K.S.; Faust, K.A.; Chen, T.B.; Lotti, V.J.; Kivlighn, S.D.; Zingaro, G.J.; Greenlee, W.J. 1995: AT-1 selective angiotensin II antagonists with phenoxyphenylacetic acid as a biphenyl replacement part I. Bioorganic and Medicinal Chemistry Letters 5(2): 155-158

Ashton, Wallace T.; Chang, Linda L.; Flanagan, Kelly L.; Mantlo, Nathan B.; Ondeyka, Debra L.; Kim, Dooseop; De Laszlo, Stephen E.; Glinka, Tomasz W.; Rivero, Ralph A.; Kevin, Nancy J.; Chang, Raymond S.L.; Siegl, Peter K.S.; Kivlighn, Salah D.; Greenlee, William J. 1995: AT-1/AT-2-balanced angiotensin II antagonists. European Journal of Medicinal Chemistry 30(Suppl ): 255S-266S

Johren, O.; Inagami, T.; Saavedra, J.M. 1995: AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain. Neuroreport 6(18): 2549-2552

Sardinia, M.F.; Hanesworth, J.M.; Krebs, L.T.; Harding, J.W. 1993: AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides. Peptides 14(5): 949-954

Sardinia, M.F.; Hanesworth, J.M.; Krishnan, F.; Harding, J.W. 1994: AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues. Peptides 15(8): 1399-1406

Kawamura, S.; Yasui, N.; Shirasawa, M.; Fukasawa, H. 1993: AT-877, a Ca2+ antagonist, fails to reduce infarct size following rat middle-cerebral artery occlusion. Acta Neurologica Scandinavica 88(4): 269-272

Boehm, S.; Brunotte, P.; Link, A. 1995: AT-III-deficiency in young adults with stroke. Aktuelle Neurologie 22(5): 203-205

Aravind, L.; Landsman, D. 1998: AT-hook motifs identified in a wide variety of DNA-binding proteins. Nucleic Acids Research 26(19): 4413-4421

Hou, J.H.; Wei, Y.H. 1998: AT-rich sequences flanking the 5'-end breakpoint of the 4977-bp deletion of human mitochondrial DNA are located between two bent-inducing DNA sequences that assume distorted structure in organello. Mutation Research 403(1-2): 75-84

Ramalingam, R.; Blume, J.E.; Ganguly, K.; Ennis, H.L. 1995: AT-rich upstream sequence elements regulate spore germination-specific expression of the Dictyostelium discoideum celA gene. Nucleic Acids Research 23(15): 3018-3025

Worck, R.H.; Frandsen, E.; Ibsen, H.; Petersen, J.S. 1998: AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia. Hypertension 31(1 Part 2): 384-390

Marsigliante, S.; Resta, L.; Muscella, A.; Vinson, G.P.; Marzullo, A.; Storelli, C. 1996: AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma. Cancer Letters 110(1-2): 19-27

Gillies, L.K.; Lu, M.; Wang, H.; Lee, R.M. 1997: AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats. Hypertension 30(6): 1471-1478

Lu, D.; Yang, H.; Raizada, M.K. 1998: AT1 receptor-mediated nuclear translocation of Raf-1 in brain neurons. Journal of Neurochemistry 70(1): 424-427

Camara, A.K.; Osborn, J.L. 1998: AT1 receptors mediate chronic central nervous system AII hypertension in rats fed high sodium chloride diet from weaning. Journal of the Autonomic Nervous System 72(1): 16-23

Wolf, G.; Schneider, A.; Helmchen, U.; Stahl, R.A. 1998: AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis. Experimental Nephrology 6(2): 112-120

Kuizinga, M.C.; Smits, J.F.; Arends, J.W.; Daemen MJAP 1998: AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. Journal of Molecular and Cellular Cardiology 30(2): 425-434

Gohlke, P.; Pees, C.; Unger, T. 1998: AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31(1 Part 2): 349-355

Hsu, H.; Solovyev, I.; Colombero, A.; Elliott, R.; Kelley, M.; Boyle, W.J. 1997: ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. Journal of Biological Chemistry 272(21): 13471-13474

Yasuda, H.; Mizuno, A.; Tamaoki, T.; Morinaga, T. 1994: ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene. Molecular and Cellular Biology 14(2): 1395-1401

Okuyama, Y.; Sowa, Y.; Fujita, T.; Mizuno, T.; Nomura, H.; Nikaido, T.; Endo, T.; Sakai, T. 1996: ATF site of human RB gene promoter is a responsive element of myogenic differentiation. Febs Letters 397(2-3): 219-224

Shuman, J.D.; Cheong, J.; Coligan, J.E. 1997: ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation. Journal of Biological Chemistry 272(19): 12793-12800

Livingstone, C.; Patel, G.; Jones, N. 1995: ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO Journal 14(8): 1785-1797

van Dam, H.; Wilhelm, D.; Herr, I.; Steffen, A.; Herrlich, P.; Angel, P. 1995: ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO Journal 14(8): 1798-1811

Pescini, R.; Kaszubska, W.; Whelan, J.; DeLamarter, J.F.; Hooft van Huijsduijnen, R. 1994: ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. Journal of Biological Chemistry 269(2): 1159-1165

Yanai, K.; Murakami, K.; Fukamizu, A. 1997: ATF-like element contributes to hepatic activation of human angiotensinogen promoter. Biochemical and Biophysical Research Communications 237(1): 158-162

Desdouets, C.; Ory, C.; Matesic, G.; Soussi, T.; Bréchot, C.; Sobczak-Thépot, J. 1996: ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter. Febs Letters 385(1-2): 34-38

Liang, G.; Wolfgang, C.D.; Chen, B.P.; Chen, T.H.; Hai, T. 1996: ATF3 gene. Genomic organization, promoter, and regulation. Journal of Biological Chemistry 271(3): 1695-1701

Dugan, M.J.; Defor, T.E.; Steinbuch, M.; Filipovich, A.H.; Weisdorf, D.J. 1997: ATG plus corticosteroid therapy for acute graft-versus-host disease: Predictors of response and survival. Annals of Hematology 75(1-2): 41-46

Trivedi, H.S.; Lal, S.M.; Gupta, N.; Ross, G. 1996: ATGAM associated coagulopathy in renal transplant patients: a report of two unusual cases. International Journal of Artificial Organs 19(8): 448-450

van Gennip, E.M.; Talmon, J.L.; Bakker, A.R. 1994: ATIM, accompanying measure on the assessment of information technology in medicine. Computer Methods and Programs in Biomedicine 45(1-2): 5-8

Uchiyama, T. 1996: ATL and HTLV-I: in vivo cell growth of ATL cells. Journal of Clinical Immunology 16(6): 305-314

Matsuoka, M.; Hattori, T.; Nishimura, Y.; Takatsuki, K. 1995: ATL cells recognize self class II HLA antigens: implication to leukemogenesis. Leukemia 9(8): 1338-1343

Ben-Abraham, R.; Stein, M.; Kluger, Y.; Blumenfeld, A.; Rivkind, A.; Shemer, J. 1997: ATLS course in emergency medicine for physicians?. Harefuah 132(10): 695-7 743

Townsend, R.N.; Clark, R.; Ramenofsky, M.L.; Diamond, D.L. 1993: ATLS-based videotape trauma resuscitation review: education and outcome. Journal of Trauma 34(1): 133-138

Lim, D.S.; Kirsch, D.G.; Canman, C.E.; Ahn, J.H.; Ziv, Y.; Newman, L.S.; Darnell, R.B.; Shiloh, Y.; Kastan, M.B. 1998: ATM binds to beta-adaptin in cytoplasmic vesicles. Proceedings of the National Academy of Sciences of the United States of America 95(17): 10146-10151

Broeks, A.; de Klein, A.; Floore, A.N.; Muijtjens, M.; Kleijer, W.J.; Jaspers, N.G.; van 't Veer, L.J. 1998: ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population. Human Mutation 12(5): 330-337

Stankovic, T.; Kidd, A.M.; Sutcliffe, A.; McGuire, G.M.; Robinson, P.; Weber, P.; Bedenham, T.; Bradwell, A.R.; Easton, D.F.; Lennox, G.G.; Haites, N.; Byrd, P.J.; Taylor, A.M. 1998: ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. American Journal of Human Genetics 62(2): 334-345

Vorechovský, I.; Luo, L.; Lindblom, A.; Negrini, M.; Webster, A.D.; Croce, C.M.; Hammarström, L. 1996: ATM mutations in cancer families. Cancer Research 56(18): 4130-4133

Sasaki, T.; Tian, H.; Kukita, Y.; Inazuka, M.; Tahira, T.; Imai, T.; Yamauchi, M.; Saito, T.; Hori, T.; Hashimoto-Tamaoki, T.; Komatsu, K.; Nikaido, O.; Hayashi, K. 1998: ATM mutations in patients with ataxia telangiectasia screened by a hierarchical strategy. Human Mutation 12(3): 186-195

Vaziri, H.; West, M.D.; Allsopp, R.C.; Davison, T.S.; Wu, Y.S.; Arrowsmith, C.H.; Poirier, G.G.; Benchimol, S. 1997: ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO Journal 16(19): 6018-6033

Rotman, G.; Shiloh, Y. 1998: ATM: from gene to function. Human Molecular Genetics 7(10): 1555-1563

Mizoguchi, T.; Hayashida, N.; Yamaguchi-Shinozaki, K.; Kamada, H.; Shinozaki, K. 1993: ATMPKs: a gene family of plant MAP kinases in Arabidopsis thaliana. Febs Letters 336(3): 440-444

Venglarik, C.J.; Schultz, B.D.; Frizzell, R.A.; Bridges, R.J. 1994: ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism. Journal of General Physiology 104(1): 123-146

Ballatori, N.; Truong, A.T.; Jackson, P.S.; Strange, K.; Boyer, J.L. 1995: ATP depletion and inactivation of an ATP-sensitive taurine channel by classic ion channel blockers. Molecular Pharmacology 48(3): 472-476

Bardoni, R.; Goldstein, P.A.; Lee, C.J.; Gu, J.G.; MacDermott, A.B. 1997: ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(14): 5297-5304

Green, A.C.; Dowdall, M.J.; Richardson, C.M. 1997: ATP acting on P2Y receptors triggers calcium mobilization in Schwann cells at the neuroelectrocyte junction in skate. Neuroscience 80(2): 635-651

Strøbaek, D.; Christophersen, P.; Dissing, S.; Olesen, S.P. 1996: ATP activates K and Cl channels via purinoceptor-mediated release of Ca2+ in human coronary artery smooth muscle. American Journal of Physiology 271(5 Pt 1): C1463-C1471

Boland, B.; Himpens, B.; Vincent, M.F.; Gillis, J.M.; Casteels, R. 1992: ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens. British Journal of Pharmacology 107(4): 1152-1158

Sugasawa, M.; Erostegui, C.; Blanchet, C.; Dulon, D. 1996: ATP activates a cation conductance and Ca(2+)-dependent Cl- conductance in Hensen cells of guinea pig cochlea. American Journal of Physiology 271(6 Pt 1): C1817-C1827

Post, S.R.; Rump, L.C.; Zambon, A.; Hughes, R.J.; Buda, M.D.; Jacobson, J.P.; Kao, C.C.; Insel, P.A. 1998: ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells. Journal of Biological Chemistry 273(36): 23093-23097

Amédée, T.; Despeyroux, S. 1995: ATP activates cationic and anionic conductances in Schwann cells cultured from dorsal root ganglia of the mouse. Proceedings. Biological Sciences 259(1356): 277-284

Sugasawa, M.; Erostegui, C.; Blanchet, C.; Dulon, D. 1996: ATP activates non-selective cation channels and calcium release in inner hair cells of the guinea-pig cochlea. Journal of Physiology 491: 707-718

Pokorski, M.; Strosznajder, R. 1997: ATP activates phospholipase C in the cat carotid body in vitro. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 48(3): 443-450

Ikeuchi, Y.; Nishizaki, T. 1995: ATP activates the potassium channel and enhances cytosolic Ca2+ release via a P2Y purinoceptor linked to pertussis toxin-insensitive G-protein in brain artery endothelial cells. Biochemical and Biophysical Research Communications 215(3): 1022-1028

Berberián, G.; Helguera, G.; Beaugé, L. 1993: ATP activation of plasma membrane yeast H(+)-ATPase shows complex kinetics independently of the degree of purification. Biochimica Et Biophysica Acta 1153(2): 283-288

Bystrom, C.E.; Pettigrew, D.W.; Rennington, S.J.; Branchaud, B.P. 1997: ATP analogs with non-transferable groups in the gamma position as inhibitors of glycerol kinase. Bioorganic and Medicinal Chemistry Letters 7(20): 2613-2616

Rugolo, M.; Mastrocola, T.; Whörle, C.; Rasola, A.; Gruenert, D.C.; Romeo, G.; Galietta, L.J. 1993: ATP and A1 adenosine receptor agonists mobilize intracellular calcium and activate K+ and Cl- currents in normal and cystic fibrosis airway epithelial cells. Journal of Biological Chemistry 268(33): 24779-24784

Napiwotzki, J.; Shinzawa-Itoh, K.; Yoshikawa, S.; Kadenbach, B. 1997: ATP and ADP bind to cytochrome c oxidase and regulate its activity. Biological Chemistry 378(9): 1013-1021

Elhamdani, A.; Bossu, J.L.; Feltz, A. 1995: ATP and G proteins affect the runup of the Ca2+ current in bovine chromaffin cells. Pflugers Archiv: European Journal of Physiology 430(3): 410-419

Nelson, J.W.; Zhu, J.; Smith, C.C.; Kulka, M.; Aurelian, L. 1996: ATP and SH3 binding sites in the protein kinase of the large subunit of herpes simplex virus type 2 of ribonucleotide reductase (ICP10). Journal of Biological Chemistry 271(29): 17021-17027

Merten, M.D.; Breittmayer, J.P.; Figarella, C.; Frelin, C. 1993: ATP and UTP increase secretion of bronchial inhibitor by human tracheal gland cells in culture. American Journal of Physiology 265(5 Pt 1): L479-L484

Tsuda, T.; Kaya, S.; Yokoyama, T.; Hayashi, Y.; Taniguchi, K. 1998: ATP and acetyl phosphate induces molecular events near the ATP binding site and the membrane domain of Na+,K+-ATPase. The tetrameric nature of the enzyme. Journal of Biological Chemistry 273(38): 24339-24345

Shimegi, S. 1996: ATP and adenosine act as a mitogen for osteoblast-like cells (MC3T3-E1). Calcified Tissue International 58(2): 109-113

Piper, A.S.; Hollingsworth, M. 1996: ATP and beta,gamma-methylene ATP produce relaxation of guinea-pig isolated trachealis muscle via actions at P1 purinoceptors. European Journal of Pharmacology 307(2): 183-189

Ono, S.; Mougouris, T.; DuBose, T.D.; Sansom, S.C. 1994: ATP and calcium modulation of nonselective cation channels in IMCD cells. American Journal of Physiology 267(4 Pt 2): F558-F565

San Juan Serrano, F.; Luis Sanchez Lopez, J.; Oscar Garcia Martin, L. 1998: ATP and energy charge regulate glycogen phosphorylase from Mytilus galloprovincialis mantle. Comparative Biochemistry and Physiology B 120(3): 483-491

Robertson, S.J.; Edwards, F.A. 1998: ATP and glutamate are released from separate neurones in the rat medial habenula nucleus: Frequency dependence and adenosine-mediated inhibition of release. Journal of Physiology 508: 691-701

Kornberg, A.; Kornberg, A. 1993: ATP and inorganic pyro- and polyphosphate. Protein Science: a Publication of the Protein Society 2(1): 131-132

Smits, G.J.; Lefebvre, R.A. 1996: ATP and nitric oxide: Inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum. British Journal of Pharmacology 118(3): 695-703

Sárváry, E.; Halsey, J.H.; Conger, K.A.; Garcia, J.H.; Kovách, A.G. 1994: ATP and pH predictors of histologic damage following global cerebral ischemia in the rat. Acta Physiologica Hungarica 82(2): 109-124

Kujawa, S.G.; Fallon, M.; Bobbin, R.P. 1994: ATP antagonists cibacron blue, basilen blue and suramin alter sound-evoked responses of the cochlea and auditory nerve. Hearing Research 78(2): 181-188

Nakazawa, K.; Koizumi, S.; Inoue, K. 1995: ATP as a neurotransmitter in the brain: its possibility based upon recent findings. Nihon Shinkei Seishin Yakurigaku Zasshi 15(1): 1-11

Arnett, T.R.; King, B.F. 1997: ATP as an osteoclast regulator?. Journal of Physiology 503: 236

Castaño, A.; Tarazona, J.V. 1994: ATP assay on cell monolayers as an index of cytotoxicity. Bulletin of Environmental Contamination and Toxicology 53(2): 309-316

Duda, T.; Sharma, R.K. 1995: ATP bimodal switch that regulates the ligand binding and signal transduction activities of the atrial natriuretic factor receptor guanylate cyclase. Biochemical and Biophysical Research Communications 209(1): 286-292

Panaretou, B.; Prodromou, C.; Roe, S.M.; O'Brien, R.; Ladbury, J.E.; Piper, P.W.; Pearl, L.H. 1998: ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO Journal 17(16): 4829-4836

Guthapfel, R.; Guéguen, P.; Quéméneur, E. 1996: ATP binding and hydrolysis by the multifunctional protein disulfide isomerase. Journal of Biological Chemistry 271(5): 2663-2666

Turina, P.; Capaldi, R.A. 1994: ATP binding causes a conformational change in the gamma subunit of the Escherichia coli F1ATPase which is reversed on bond cleavage. Biochemistry 33(47): 14275-14280

Pavela-Vrancic, M.; Pfeifer, E.; van Liempt, H.; Schäfer, H.J.; von Döhren, H.; Kleinkauf, H. 1994: ATP binding in peptide synthetases: Determination of contact sites of the adenine moiety by photoaffinity labeling of tyrocidine synthetase 1 with 2-azidoadenosine triphosphate. Biochemistry 33(20): 6276-6283

Llorca, O.; Smyth, M.G.; Marco, S.; Carrascosa, J.L.; Willison, K.R.; Valpuesta, J.M. 1998: ATP binding induces large conformational changes in the apical and equatorial domains of the eukaryotic chaperonin containing TCP-1 complex. Journal of Biological Chemistry 273(17): 10091-10094

Freist, W.; Verhey, J.F.; Stühmer, W.; Gauss, D.H. 1998: ATP binding site of P2X channel proteins: Structural similarities with class II aminoacyl-tRNA synthetases. FEBS Letters 434(1-2): 61-65

Bauer, M.; Baumann, J.; Trommer, W.E. 1992: ATP binding to bovine serum albumin. Febs (federation Of European Biochemical Societies) Letters. 313(3): 288-290

Hingorani, M.M.; O'Donnell, M. 1998: ATP binding to the Escherichia coli clamp loader powers opening of the ring-shaped clamp of DNA polymerase III holoenzyme. Journal of Biological Chemistry 273(38): 24550-24563

Pérez-Martín, J.; de Lorenzo, V. 1996: ATP binding to the sigma 54-dependent activator XylR triggers a protein multimerization cycle catalyzed by UAS DNA. Cell 86(2): 331-339